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Abstract   29 
During embryogenesis cells make fate decisions within complex tissue environments. 30 
The levels and dynamics of transcription factor expression regulate these decisions. 31 
Here we use single cell live imaging of an endogenous HES5 reporter and absolute 32 
protein quantification to gain a dynamic view of neurogenesis in the embryonic 33 
mammalian spinal cord. We report that dividing neural progenitors show both 34 
aperiodic and periodic HES5 protein fluctuations. Mathematical modelling suggests 35 
that in progenitor cells the HES5 oscillator operates close to its bifurcation boundary 36 
where stochastic conversions between dynamics are possible. HES5 expression 37 
becomes more frequently periodic as cells transition to differentiation which, coupled 38 
with an overall decline in HES5 expression, creates a transient period of oscillations 39 
with higher fold expression change. This increases the decoding capacity of HES5 40 
oscillations and correlates with interneuron versus motor neuron cell fate. Thus, 41 
HES5 undergoes complex changes in gene expression dynamics as cells 42 
differentiate.  43 
 3
Introduction 44 
 45 
During embryogenesis cells balance proliferation with differentiation to make cell 46 
state transitions that lead to the formation of functional organs. This is exemplified by 47 
development of the central nervous system, which requires the balance of neural 48 
progenitor maintenance with differentiation during multiple waves of differentiation in 49 
to neuronal and glial cell-types1. In the dorso-ventral (D-V) axis of the spinal cord 50 
elegant experiments have shown that fate decisions require integration of a wide 51 
range of signals over time, many in the form of morphogen gradients, resulting in 52 
downstream gene expression changes2,3.  53 
 54 
Single-cell transcriptomics have greatly enhanced our understanding of gene 55 
expression changes and networks involved in fate decisions and of the bifurcation 56 
points where decisions are made4–7. However advances in single-cell live imaging of 57 
gene expression have shown that it is often highly dynamic, suggesting that the 58 
control of cell state transitions is more complex8–10. Rather than being in an on or off 59 
state, a handful of transcription factors have been shown to oscillate with periodicity 60 
of a few hours9,11. Oscillations have been long described in somitogenesis12, but are 61 
a relatively recent discovery in neurogenesis. This is because unlike somitogenesis 62 
where oscillations are synchronous within each somite, they tend to be 63 
asynchronous in neural progenitor cells (NPCs) and so required unstable reporters 64 
and single cell imaging to be discovered13. Thus, it is not only changes in gene 65 
expression levels that are important, but the short term dynamics of gene expression 66 
can also carry important information for cell state transitions. Indeed, there is 67 
experimental and theoretical evidence that cell fate transitions may be controlled by a 68 
change in the dynamic pattern of gene expression, which could be from oscillatory to 69 
stable expression, or to oscillatory with different characteristics9,14,15.  70 
 71 
In the case of the transcriptional repressor HES1, a key target of Notch signaling, it 72 
has been known that oscillatory expression is driven by transcriptional auto-73 
repression coupled with delays, instability of mRNA and protein and non-linearity of 74 
reactions, common principles of many biological oscillators16,17. Like HES1, HES5 is 75 
a Notch target bHLH transcription factor (TF) which is highly expressed by NPCs and 76 
decreases in expression as differentiation proceeds18,19. Knock-out mice and over-77 
expression studies have shown that HES5 functions to maintain the undifferentiated 78 
progenitor state through repression of proneural genes, such as Neurog2 and Atoh1 79 
that promote neuronal differentiation20–22. Like HES1, HES5 has been reported to 80 
oscillate in NPCs in vitro9.  81 
 82 
Changes in HES1 dynamics are mediated by a change of the parameters or initial 83 
conditions of the oscillator, likely through changes in mRNA stability or protein 84 
translation under the influence of a microRNA, miR-923–25.  Other theoretical studies 85 
provide additional support for the importance of a change in dynamics by showing 86 
that gene expression networks in the D-V dimension of the spinal cord can generate 87 
multi-way switches (stable or oscillatory)26. 88 
 89 
An additional revelation of single-cell live imaging studies is that gene expression is 90 
characterised by varying degrees of noise due to the stochastic nature of 91 
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transcription27–29. Current ideas for the role of such embedded stochasticity include 92 
cases where it would be an advantage30,31 or conversely, an impediment for cell fate 93 
decisions32,33 and mechanisms to suppress noise after a fate-decision34.   94 
 95 
However, although these studies have shed new light into the problem of cell-state 96 
transition, how cells make decision in the context of multicellular tissue is poorly 97 
understood. This is because both single-cell transcriptomics and live imaging data 98 
are routinely performed in single cells taken out of the tissue environment. Existing 99 
studies of oscillatory expression in the mouse brain and spinal cord lack the 100 
statistical power needed to give a comprehensive understanding of the dynamics in 101 
the tissue11,35. A study using electroporation of a promoter reporter of Hes5-1 in 102 
chicken spinal cord tissue reported activation of Notch signaling throughout the 103 
progenitor cell cycle but most frequently before mitosis36. However, this approach 104 
suffered from plasmid loss and varying degrees of plasmid transfection and did not 105 
report on endogenous HES5.  106 
 107 
Here, we develop ex-vivo slice culture of embryonic Venus::HES5 knock-in mouse 108 
spinal cord (E10.5) to study the expression dynamics of HES5 in the context of a 109 
tissue, with single cell resolution. We report that HES5 expression has a 10-fold 110 
range between cells in a single expression domain that arises from short-term 111 
fluctuations and longer-term trends of decreasing HES5. We use hierarchical 112 
clustering to define distinct clusters of single cell HES5 expression dynamics. New 113 
statistical tools show that oscillatory HES5 is more frequently observed in cells that 114 
transition towards differentiation where it is coupled with an overall decrease in HES5 115 
expression generating larger instantaneous fold changes. Oscillatory decline of 116 
HES5 correlates with interneuron fate, suggesting the dynamics are decoded in the 117 
choice of cell fate. By contrast, dividing NPCs are less frequently periodic but 118 
significantly more noisy in their HES5 expression. Computational modelling with 119 
stochastic differential delay equations, parameterised using experimental values and 120 
Bayesian inference, suggest that in the spinal cord tissue environment the Hes5 121 
genetic oscillator operates close to a bifurcation point where noise can tip it from 122 
aperiodic to periodic expression. Taken together, our findings suggest that single 123 
progenitor cells in a tissue are noisy and are thus primed to enter a transient 124 
oscillatory phase as the cells differentiate. Additionally, our study shows that tissue 125 
level single-cell heterogeneity has a complex origin in both short and long term 126 
dynamics and that the dynamics are decoded en route to differentiation where they 127 
correlate with the choice of cell fate that the cells adopt.    128 
 129 
 130 
Results  131 
Venus::HES5 reporter recapitulates endogenous features 132 
We characterised the Venus::HES5 knock-in mouse9 to ensure that it is a faithful 133 
reporter of the un-tagged gene. In transverse sections of E10.5 spinal cord 134 
Venus::HES5 shows a broad ventral and a smaller dorsal domain (Fig.1a). The 135 
ventral domain, which is the focus of this study, encompasses mainly ventral 136 
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interneuron (p0-p2) and ventral motor neuron progenitors (pMN) (Supplementary Fig. 137 
1a,b). HES5 is expressed in NPCs and declines in neuronal cells (Fig. 1b), 138 
consistent with reports of endogenous HES57.  139 
Both mRNA and protein half-lives of Venus::HES5 are unstable with similar values to 140 
untagged HES5 (approximately 30 mins for the mRNA and 80-90 mins for the 141 
protein). These findings confirm that the Venus::HES5 fusion protein is a faithful 142 
reporter of endogenous un-tagged HES5 expression (Supplementary Fig. 1c-f).    143 
Quantification of range and level of HES5 expression 144 
Dynamic expression can give rise to tissue level single-cell heterogeneity which may 145 
be masked by population averaging. Here we use absolute quantitation of 146 
Venus::HES5 molecules at the single cell level by Fluorescence Correlation 147 
Spectroscopy (FCS) in live homozygous Venus::HES5 E10.5 embryo slices (Fig. 148 
1c,d Supplementary Fig. 2a-d). FCS is an absolute quantification method that 149 
records fluorescence emitted as molecules diffuse through a minute volume37. The 150 
temporal correlation of the signal over time is indicative of the number of molecules 151 
present and their diffusion characteristics. Ssing FCS on wild-type E10.5 spinal cord 152 
tissue we confirmed that unlike intensity-based techniques FCS count-rate was 153 
minimally affected by auto-fluorescence, (Supplementary Fig. 2b). In Venus::HES5+/+ 154 
embryos single cells showed a 10-fold range of nuclear Venus::HES5 protein 155 
expression within the ventral Venus::HES5 expression domain, from 26nM to 319nM. 156 
(Fig. 1d). The mean Venus::HES5 nuclear concentration was calculated as 140nM, 157 
or 46,250 molecules per nucleus. Heterozygous embryos showed lower mean 158 
protein expression, as could be expected by monitoring the expression of one allele 159 
(Supplementary Fig. 2e). These findings show a high degree of variability in 160 
Venus::HES5 expression between cells which is similar in homozygous and 161 
heterozygous embryos suggesting that integrating the expression from 2 alleles does 162 
not diminish the variability that cells experience.  163 
Quantitative map of HES5 expression heterogeneity 164 
FCS can be performed for a limited number of live cells in the tissue, while an 165 
intensity map of the Venus signal can be obtained for all cells from snapshot images. 166 
We combined the two approaches38 by plotting the distribution of single-cell 167 
Venus::HES5 intensities from manual segmentation of nuclei in a single slice (Fig. 168 
1g) against the distribution of single-cell FCS protein concentration (Fig. 1h) over 169 
multiple slices and experiments. The resulting quantile-quantile (Q-Q) plot was linear 170 
and only deviated from linearity at the very high and low values (Fig. 1i). We 171 
therefore translate intensity in an image into protein concentration (Fig. 1j) by scaling 172 
the intensity value by the gradient of the linear Q-Q plot. Once the Venus::HES5 173 
concentration distribution has been obtained it can be applied to multiple images to 174 
generate more quantitative maps without needing to repeat the FCS (Supplementary 175 
Fig. 2f,g).  176 
 177 
We used the quantitative map to investigate global and local patterns of HES5 178 
concentration. We split the ventral domain into 2 regions due to the difference in 179 
width of the ventricular zone along the D-V axis (indicated by boxes in Fig. 1j) We 180 
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observed a non-linear global reduction of Venus::HES5 concentration with increasing 181 
distance from the ventricle (Fig. 1k). The shoulder-point corresponded to around 182 
50μm and 30μm in the dorsal-most (1) and ventral-most (2) regions respectively, 183 
suggesting that at this distance, cells start to decrease HES5. At any given distance 184 
there is large cell-to-cell variability in Venus::HES5 concentration. The concentration 185 
difference between a cell and its nearest neighbour (Supplementary Fig. 2h) 186 
increased further away from the ventricle, reaching a maximum of 191nM, a 4.5-fold 187 
difference (Fig. 1l). This trend was confirmed in embryos that had not undergone 188 
intensity:concentration scaling (Fig. 1m). Thus, further from the ventricle a global 189 
reduction of Venus::HES5 expression is accompanied by increasing heterogeneity. 190 
 191 
Clustering indicates distinct Venus::HES5 expression dynamics 192 
Single cell expression heterogeneity may be the result of multiple possibilities: i) 193 
fluctuating expression alone (Fig. 2b), which could be periodic and asynchronous ii) 194 
distinct but stable cell-state subpopulations (Fig. 2c) or iii) an expression decline as 195 
cells transition from one stable state to another (Fig. 2d). Hypothesis (i) implies HES5 196 
expression satisfies ergodicity, i.e. variability in a single cell over time can 197 
recapitulate the tissue level heterogeneity39. To resolve potential mechanisms that 198 
generate heterogeneity, we performed live imaging of Venus::HES5 expression 199 
dynamics in ex-vivo slices. We used tamoxifen-dependent recombination in SOX1+ 200 
cells 18hrs prior to imaging to label NPCs or cells of neuronal progeny with 201 
H2B::mCherry (Fig. 2e,f).  202 
We observed multiple types of single-cell Venus::HES5 dynamic behaviours in 203 
heterozygous cells (Fig. 2g) over a time period of 12-15 hours. Hierarchical clustering 204 
of the standardised Venus::HES5 intensity timeseries suggested 4 clusters of long-205 
term Venus::HES5 expression dynamics (Fig. 2h and Supplementary Fig. 4a,b).  206 
Cells in cluster 1 and 2 showed fluctuating expression around a stable mean 207 
whereas cells in clusters 3 and 4 showed gradually decreasing and fluctuating HES5 208 
expression (Fig. 2h). The non-standardised mean expression of cells in each cluster 209 
maintained this trend (Fig. 2i) which is further exemplified by single cell traces (Fig. 210 
2j).  211 
The coefficient of variation (C.O.V, standard deviation of intensity divided by the 212 
mean intensity) of Venus::HES5 over time in single cells increased over 4,8,12,14.25 213 
and 17.25 hours (Fig. 2k). By 8-12 hours multiple cells in clusters 3 and 4 had 214 
reached similar or higher levels of variation as the variation observed between cells 215 
at a single snapshot (Fig. 2h) suggesting that declining expression is a major 216 
contributor to the tissue heterogeneity. In contrast, cells in clusters 1 and 2 rarely 217 
reached tissue-levels of variation between cells, suggesting that short-term dynamics 218 
have a lesser contribution to overall tissue heterogeneity and excluding scenario in 219 
Fig. 2b. Thus heterogeneity is generated by a mix of declining expression (long-term 220 
trends, scenario Fig. 2d,) and dynamic fluctuations (short term dynamics) around a 221 
slowly varying mean.  222 
Venus::HES5 expression dynamics correlate with cell-states  223 
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We hypothesise that the different clusters of Venus::HES5 expression may represent 224 
different cell-states. It is well known that proliferating NPCs (SOX1+/2+) are found 225 
apically in the ventricular zone, undergo inter-kinetic nuclear migration (INM) dividing 226 
at the apical surface1,40. Newly born cells fated towards neuronal differentiation 227 
migrate basally away from the apical surface, exit the cell cycle and turn on markers 228 
of differentiation (Tuj1 and NeuN)40. We therefore sought to infer cell state by 229 
position, motility and division of cells using progenitor/neuronal immunochemistry 230 
data in ex-vivo slices as reference.  231 
The average position of cells in cluster 1 was significantly closer to the ventricle than 232 
those in cluster 3 (Fig. 3c). Further, in a zone greater than 50μm from the ventricle 233 
very few cells of cluster 1 reside and cells in cluster 3 are more abundant (Fig. 3d). 234 
By contrast, the zone within the first 50μm of the ventricle is equally occupied by cells 235 
in clusters 1-4 (Fig. 3d).  236 
Nuclei of cells in cluster 1 moved both apically and basally, consistent with inter-237 
kinetic nuclear migration (INM) but had the shortest displacement as they returned 238 
apically. Meanwhile nuclei of cells in cluster 3 and 4 had a larger displacement which 239 
was unidirectional towards the basal side (Fig. 3a,b,e,f, Supplementary Fig. 5a and 240 
Supplementary Movie 1) suggesting they are on their way to differentiation. 241 
Immunostaining and measurement of the SOX2+ domain showed that many cells in 242 
cluster 3 and 4 moved out from the SOX2+ zone into the mantle zone with 243 
concurrent decreasing Venus::HES5 (Fig.3a,b, Supplementary Fig. 5b,c,d). 244 
H2B::mCherry dynamics did not decrease in level, neither close nor far away from 245 
the ventricle, and were similar between clusters (Supplementary Fig. 4c,5e). 246 
Cells divided at the apical surface (Supplementary Fig. 5f) and the number of  247 
divisions was significantly higher in cluster 1 and 2; indeed, very few cells in cluster 4 248 
and no cells in cluster 3 were observed to divide (Fig. 3g). Given these findings, we 249 
inferred that cells in cluster 1 and 2 are proliferating progenitors and cells in cluster 3 250 
and 4 are transitioning towards differentiation. 251 
What are the differences between cluster 1 and 2 and between clusters 3 and 4? We 252 
inferred cell-cycle phase based on cell position and trajectory and we found no 253 
difference in the cell cycle profiles between cells in cluster 1 and 2 (Supplementary 254 
Fig. 5g). Cells in cluster 1 have higher levels of Venus::HES5 than cells in cluster 2 255 
when levels are normalized for z-depth of the cell into the tissue (Supplementary Fig. 256 
5h). Cells in cluster 4 tend to be delayed in the decrease in Venus::HES5 levels 257 
compared to cells in cluster 3 (Fig. 2i) and show a small total number of divisions 258 
(14%; Fig. 3g), in contrast to 1.5% of divisions in cluster 3.  259 
We confirmed our interpretation of cell-state by using the Notch inhibitor DBZ to 260 
promote differentiation7. Spinal cord ex-vivo slices treated with 2μM DBZ showed 261 
significantly lower mean Venus::HES5 intensity than control (Fig. 4a, Supplementary 262 
Fig. 6a) and an increase in the early neuronal marker β-tubulin especially in apical 263 
regions (Fig. 4b). The disorganisation of the neural tube in DBZ treated slices is 264 
similar to Hes KO phenotypes41, consistent with Hes5 being a downstream target of 265 
Notch. The average position of single cells in DBZ treated slices was further from the 266 
ventricle (Supplementary Fig. 6b) and they showed significantly increased apico-267 
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basal displacement confirming that Notch inhibition had pushed cells towards basal 268 
migration and differentiation (Fig. 4c). Hierarchical clustering of standardised 269 
Venus::HES5 single-cell intensities showed that 98% of cells in the DBZ treated 270 
slices were found in clusters 3 and 4 (Fig. 4d,e). Specifically, the timing of 271 
Venus::HES5 decline, the COV of Venus::HES5 over time and the number of 272 
divisions is consistent with most of the DBZ treated cells falling into cluster 4-type 273 
dynamics (Supplementary Fig. 6c,d,e), while the distribution of control DMSO 274 
Venus::HES5 cells recapitulated the presence of all 4 clusters  (Supplementary Fig. 275 
6f,g).  276 
We conclude that cells characterised by a temporally fluctuating Venus::HES5 277 
expression pattern around a high mean (cluster 1 and 2) are proliferating NPCs 278 
maintained by Notch signalling, while cells with decreasing Venus::HES5 levels over 279 
time (clusters 3 and 4) are neural cells undergoing cell state transition to 280 
differentiation. We do not know the significance of the subtle differences between 281 
clusters 1 and 2 or 3 and 4 but we suggest that the simplest interpretation of our data 282 
is that clusters 1+2 give rise to clusters 3+4. However more complex alternatives 283 
may exist, such as subtle heterogeneity in progenitors translated linearly to neuronal 284 
progeny heterogeneity.  285 
 286 
Differentiating cells are oscillatory and progenitors noisy 287 
Previous reports show periodic HES5 expression in embryonic mouse cortical NPCs 288 
using luciferase and fluorescence imaging9 but statistical analysis has not been 289 
performed. Here, we have focused on the endogenous Venus::HES5 fluorescent 290 
fusion protein because unlike luciferase, it allows single cell spatial resolution in the 291 
tissue environment by confocal microscopy. The t1/2 of Venus maturation (15 mins)42 292 
is suitably short compared to HES5 protein half-life (80-90 mins, Supplementary Fig. 293 
1d). HES5 traces show a high degree of variability (Supplementary Fig. 7) and 294 
detecting oscillatory gene expression in such noisy timeseries, is challenging. We 295 
have previously developed an approach for statistical determination of oscillations in 296 
noisy bioluminescent data43. Here, we extend this method to take into account that 297 
fluorescence intensity timeseries from tissue are inherently more noisy partly 298 
because they do not involve the long integration times associated with Luciferase 299 
imaging (Methods).  300 
To analyse oscillations, we first subtracted long-term changes in level (trend) caused 301 
by HES5 downregulation (Fig. 5a). We then analysed detrended data with an 302 
oscillatory covariance model and inferred the period, amplitude and lengthscale (Fig. 303 
5b). Lengthscale accounts for variability in the peaks over time. We compared the 304 
oscillatory (alternative) model fit and aperiodic (null) covariance model fit using the 305 
log-likelihood ratio (LLR), which is high for oscillators (Supplementary Fig. 8a) and 306 
low for non-oscillators (Supplementary Fig. 8b). Finally, we identified oscillatory cells 307 
in each experiment using a strict false-discovery rate criteria set at 3% 308 
(Supplementary Fig. 8d).  309 
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We found that overall 41% of cells in E10.5 spinal cord ex-vivo showed oscillatory 310 
Venus::HES5 expression (Supplementary Fig. 9a), while the rest were fluctuating 311 
and aperiodic. The mean period of Venus::HES5 oscillations was 3.3±0.3 hours 312 
(±S.D) (Fig. 5c) while H2B::mCherry expression from the ROSA26 locus in the same 313 
nuclei was aperiodic (Supplementary Fig. 9a).  314 
We also imaged cells dissociated from the spinal cord of heterozygous Venus::HES5 315 
mouse embryos and cultured in vitro, as this matches the experimental set-up used 316 
previously9 (Supplementary Fig. 9a,b). The occurrence of oscillatory Venus::HES5 317 
expression was higher in dissociated cells compared to cells in the tissue 318 
environment (Supplementary Fig. 9a). Nuclear Venus::HES5 concentrations were 319 
also significantly lower in dissociated cells (Supplementary Fig. 9d). This finding 320 
confirms the ability of our methods to detect oscillations and further suggests that 321 
HES5 dynamics are influenced by the tissue environment, although many factors 322 
change between in vitro and ex vivo conditions. Interestingly, there was no difference 323 
in the percentage of oscillatory cells isolated from heterozygous versus homozygous 324 
mice confirming that cells experience oscillatory HES5 dynamics (Supplementary 325 
Fig. 9a,d). 326 
We next sought to determine which of the clusters contain cells with oscillatory 327 
expression. Oscillations were not restricted to proliferating progenitor cells, instead 328 
Venus::HES5 oscillations were more frequently observed in cells on their way to 329 
differentiation (clusters 3 and 4) than dividing progenitors in clusters 1 and 2  (Fig. 330 
5d). By contrast, proliferating progenitors in cluster 1 had significantly greater noise 331 
than differentiating cells in cluster 3, (noise measured by squared-standard deviation 332 
of de-trended Venus::HES5 signal (Fig. 5e)). In agreement with this, the likelihood of 333 
a cell to have oscillatory Venus::HES5 significantly increased with an increasing 334 
average distance from the ventricle (Fig. 5f), whereas noise decreased (Fig. 5g) 335 
Given that progenitor cells close to the ventricle (cluster 1 & 2) are likely to turn into 336 
the transitory and differentiating cells in cluster 3 and 4, we conclude that progenitor 337 
cells have high, dynamic and noisy Venus::HES5 expression which evolves in to a 338 
more oscillatory signal as Venus::HES5 decreases and the cells undergo 339 
differentiation. Although our observation time window is relatively short, data 340 
collected from a few cells in cluster 1 demonstrate this noisy to oscillatory transition 341 
in Venus::HES5 expression, supporting this view (Fig. 5h, Supplementary Movie 2).  342 
Hes5 network poised at aperiodic to oscillatory transition 343 
To understand how the HES5 dynamics of clusters 1 and 2 are generated and how 344 
they may transition from aperiodic to periodic expression, we used a stochastic delay 345 
differential equation model of an auto-negative feedback network (Fig.6a and  346 
Methods)30,44–46. This model applies to progenitors in clusters 1 and 2 where HES5 347 
fluctuates around a more or less stable mean. We parameterized the model using 348 
protein and mRNA half-lives (Supplementary Fig. 1c,d) and Approximate Bayesian 349 
Computation (ABC)47 to search for parameters that give rise to experimentally 350 
observed summary statistics of HES5 expression (Methods). ABC has advantages 351 
over commonly-used point estimates because it provides a probability distribution for 352 
estimated parameters thus quantifying parameter uncertainty. We found that the 353 
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experimentally measured distribution of oscillation periods and relative standard 354 
deviation values in clusters 1 and 2 (Supplementary Fig. 10a,b) are consistent with 355 
the predictions from this model (Fig. 6b,c).  356 
HES5 expression simulated from inferred parameters can be aperiodic (Fig. 6d) or 357 
oscillatory (Fig. 6e,f) depending on the parameters, as illustrated qualitatively by a 358 
sharpening of the peak in the power spectrum and expressed quantitatively by 359 
coherence30. At unique combinations of parameter values the stochastic model 360 
predicts that different proportions of aperiodic and oscillatory HES5 expression will 361 
be generated across traces and within the same trace. This is consistent with our 362 
experimental observations where less than half of cells pass oscillatory tests and we 363 
can observe changes in expression dynamics.  364 
 365 
We investigated how HES5 expression may transition from aperiodic to oscillatory in 366 
a number of ways. Firstly, we investigated how oscillation coherence varies in 367 
response to changing the protein degradation rate across parameter space using 368 
Bayesian inference (Fig. 6g where each curve corresponds to one possible 369 
parameter combination). The experimentally measured protein degradation rate 370 
(protein half-life of 90 minutes, blue-line Fig. 6g) defines a transition point where the 371 
range of possible coherence values changes sharply.  372 
 373 
We next determined the predicted coherence in relation to the protein and mRNA 374 
degradation rates for the full stochastic model (Fig. 6h) and the deterministic model 375 
(Fig. 6i). The experimentally measured mRNA and protein degradation rates were 376 
located in a region of parameter space where oscillations are expected in the 377 
stochastic model, but not in the deterministic model. This is consistent with a full 378 
Bayesian comparison between the two (Methods) where the stochastic model is 160 379 
times more likely to describe the HES5 expression statistics (Supplementary Fig. 380 
10d). Our experimentally measured degradation rates predict that the stochastic 381 
system is at the boundary of high and low coherence.  382 
 383 
Finally we explored which parameters are most likely to generate a change in 384 
dynamics between aperiodic and oscillatory HES5. Starting from parameter 385 
combinations for which the model predicts aperiodic dynamics, we changed 386 
individual model parameters by 50% and recorded the likelihood of this parameter 387 
change to induce oscillations (Fig. 6j). This indicated that a range of parameter 388 
changes have the potential to induce oscillations, among which increases in the Hill 389 
coefficient, decreases in the repression threshold and increases in protein 390 
degradation rate are the most likely options. 391 
 392 
Taken together, our modelling suggests that the HES5 oscillator in spinal cord NPCs 393 
is enabled by noise30,48 and operates very close to the boundary between aperiodic 394 
and oscillatory model dynamics, where small parameter changes can cause a 395 
transition between non-oscillatory (low coherence) and oscillatory (high coherence) 396 
expression. It also predicts that increases in the Hill coefficient, and decreases in 397 
repression threshold and protein degradation are most likely to initiate oscillatory 398 
expression  dynamics. 399 
 400 
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HES5 oscillations on a downward trend increase fold-changes 401 
Given the higher incidence of oscillatory cells in differentiating cells (cluster 3 and 4) 402 
we investigated whether HES5 oscillations are caused by the reduction of HES5 403 
levels.  The mean levels between cells is different in clusters 1 and 2, but there was 404 
no correlation with the presence of oscillations, arguing against the protein 405 
expression level alone having a causative effect for oscillations (Supplementary Fig 406 
11a,b). As expected49,50 we did find a positive relationship between Venus::HES5 407 
levels and noise (represented by absolute variance, Supplementary Fig. 11c), which 408 
was also captured by the modelling (Supplementary Fig. 11d). Further, treatment 409 
with the Notch inhibitor DBZ significantly decreases Venus::HES5 levels, enriches for 410 
cluster 4-type dynamics (Fig. 4d,e) but does not significantly change the percentage 411 
of oscillators compared to control DMSO within clusters 3 and 4 (Supplementary Fig. 412 
11e and example single cells in Supplementary Fig. 12).  413 
Why then do periodic oscillations occur predominantly during the decay in 414 
fluorescence in groups 3 and 4? The maximal peak-to-trough fold change in 415 
Venus::HES5 expression, a measure that includes the downward trend, was 416 
significantly higher in differentiating cells in clusters 3 and 4 than proliferating 417 
progenitors in cluster 1 (Fig. 7a, Supplementary Fig. 11f). Furthermore, within cluster 418 
3, oscillatory cells have a higher mean peak-to-trough fold change than non-419 
oscillatory cells (Fig. 7b,c,d), although differentiating cells eventually undergo 420 
amplitude death (Fig. 7e,f). When the declining trend was removed from the data 421 
differentiating cells no longer had the increased peak-to-trough changes 422 
(Supplementary Fig. 11g). Taken together, these findings suggest that oscillations 423 
are combined with a long-term decreasing signal to transiently promote larger fold-424 
changes in HES5 protein than either one alone, forming the decoding phase of the 425 
oscillator.  426 
 427 
Oscillatory HES5 correlates with interneuron fate 428 
To gain insight into the possible functional significance of oscillatory expression in 429 
differentiating cells, we asked whether there is a correlation between oscillatory and 430 
non-oscillatory differentiating cells in clusters 3 and 4 and the fate that the cells 431 
adopt.  Spatial patterning of the ventral spinal cord driven by Shh gradient results in 432 
clearly delineated progenitor domains that each give rise to different neuronal sub-433 
types. Therefore distance from the floorplate specifically instructs neuronal sub-type 434 
with motor neuron progenitors located more ventrally than interneuron ones. 435 
Combining the distance of cells from the floorplate and staining of the cultured ex-436 
vivo slices for motor neuron and interneuron progenitor markers, we found that there 437 
is a higher incidence of oscillatory Venus::HES5 expression in differentiating cells 438 
that give rise to interneurons than in those giving rise to motor neurons (Fig. 8a-c). 439 
We therefore conclude that there are two paths by which HES5 declines, one of 440 
which is oscillatory and one which is not, and this correlates well with the fate that 441 
these cells adopt.  442 
 443 
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Discussion 444 
We have investigated how individual Sox1+ NPCs and their progeny make cell state 445 
transitions. Our main findings are twofold: firstly, oscillatory expression of HES5 is 446 
observed in NPCs in the tissue environment but occurs more frequently and with 447 
higher fold change in cells that are transitioning towards a differentiated interneuron 448 
state (Fig. 8d). Secondly, cell-to-cell heterogeneity in HES5 in tissue is a composite 449 
of long term dynamics (decline in expression) and short term dynamics (fluctuations 450 
in a short time scale). 451 
Our findings support the view that changes in expression dynamics correlate with 452 
transitions in cell state9. However, contrary to expectations13 we observe both 453 
oscillatory and non-oscillatory HES5 dynamics within 2 defined sub-states; noisy 454 
HES5 dynamics in the proliferative progenitors and HES5 oscillatory dynamics being 455 
more likely in the cells differentiating towards interneurons. Our findings extend 456 
previous data, as the HES5 amplitude, period and dynamic behavior in tissue with 457 
statistical and computational tools have not previously described.  458 
 459 
The HES5 oscillator operates around a high mean with low peak-to-trough amplitude 460 
in dividing progenitor cells (clusters 1 and 2). The small differences in peak and 461 
trough levels may be difficult to differentially decode by downstream genes. Most 462 
likely, these oscillations are a by-product of an active negative feedback loop that is 463 
required for maintaining the HES5 level around a high mean, thus repressing pro-464 
neural genes in most apical progenitors. By contrast, oscillations in the transition to 465 
differentiation are coupled with an overall declining trend, and thus generate larger 466 
fold differences, which may be easier for downstream targets to decode. This is 467 
analogous to a ball bouncing down steps and undergoing greater instantaneous 468 
height drops (oscillatory expression) than a ball rolling down a ramp (aperiodic 469 
expression). Since HES proteins are transcriptional repressors for pro-neural genes, 470 
such as Neurog2 and Atoh121,51 we predict that the larger fold-changes generated by 471 
oscillatory decline in HES5 induces an oscillatory onset of downstream proneural 472 
genes11,35. We argue that coupling HES5 oscillations with a declining trend is an 473 
ingenious biological way for the cells to be able to decode what is normally a very 474 
shallow HES5 oscillator and importantly, to couple it with the process of 475 
differentiation. While it is known that HES5 in motor neurons is downregulated by 476 
OLIG27 it is not clear what causes the decline in interneurons. 477 
 478 
Our mathematical modelling identified that HES5 oscillations are enabled by 479 
stochastic amplification48 and that  the HES5 auto-repression network operates near 480 
a bifurcation boundary. Consequently individual cells can switch between aperiodic 481 
and periodic expression stochastically and through regulated parameter changes. 482 
Instead of considering oscillatory versus non-oscillatory cells as stable distinct 483 
subpopulations, we propose that these are readily interconverting states with 484 
considerable plasticity. The model predicts that the transition towards oscillatory 485 
behaviour is most likely regulated through changes in the Hill coefficient, repression 486 
threshold or protein degradation. Future development of this model will capture 487 
remaining features of the observed dynamics such as the down-regulation observed 488 
during the differentiation process, as observed in cells of cluster 3 and 4, as well as 489 
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other gene regulatory interactions and multi-cellular interactions.  490 
 491 
In our modeling, we have included the effects of intrinsic stochastic noise, since this 492 
does not introduce further model parameters and is associated with any rate 493 
process. Phillips et al.52 suggested that low HES1 molecule number leads to 494 
stochastic oscillations of HES1 through a finite number effect. By contrast, HES5 495 
molecule number is not low, (approximately 30-55k molecules per nucleus for HES5 496 
versus while 2-3K per nucleus for HES130). Thus other sources of noise may need to 497 
be considered perhaps stochastic activation of Notch cell-cell signalling in the 498 
densely packed tissue or cell division53 and the cell cycle.  Noise and stochasticity 499 
are often considered undesirable yet they may also benefit decision making 500 
processes30. Here the benefit of noise may be to prime HES5 expression such that it 501 
is poised to become oscillatory.  502 
The increase in cells with oscillatory HES5 in dissociated cells versus cells in tissue, 503 
is in agreement with previous suggestions of a cell-autonomous Hes oscillator which 504 
can be tuned by external signals24,52. The lack of statistical difference between the 505 
number of oscillating cells from homozygous and heterozygous Venus::HES5 506 
animals suggests, that in contrast to the stochastic transcriptional bursting54, 507 
negative feedback generated oscillations can be somewhat synchronous between 2 508 
alleles. 509 
Other genes in the Notch-Delta network such as Hes1, Dll1 and Neurog2 have been 510 
shown to oscillate in NPCs. The relative timing of pulses of different genes may 511 
regulate cellular behaviour as common target genes may respond differently to in-512 
phase or out-of-phase input pulses. Indeed, the relative phase of the Notch and Wnt 513 
signalling oscillations in somitogenesis have been proposed to control cellular 514 
differentiation55. Imaging protein expression dynamics of multiple factors in the same 515 
cell during cell fate decisions would help to reveal the relative timing of multiplexed 516 
oscillatory gene expression. 517 
The second main contribution of this paper is to increase the depth of our 518 
understanding of the degree and origin of cellular heterogeneity in gene expression 519 
in a tissue environment. We conclude that HES5 expression in the spinal cord is not 520 
an ergodic system since tissue level variability cannot be explained from short-term 521 
single cell variability but through a combination of cell sub-states co-existing in the 522 
tissue (which can be resolved spatially and dynamically) and transitions between 523 
these sub-states. A progenitor zone close to the ventricle (<50μm) shows maximum 524 
heterogeneity in cell-states, as all 4 dynamic expression clusters are equally 525 
represented in this zone, but minimum cell-to-cell heterogeneity in HES5 expression 526 
levels. By contrast, in the progenitor zone further from the ventricle there is minimum 527 
heterogeneity in cell-states, as it occupied mainly by cells in clusters 3 and 4, and 528 
maximum cell-to-cell heterogeneity in HES5 expression levels, approaching a 10-fold 529 
range in HES5. Furthermore, single cells undergoing differentiation start to down-530 
regulate Venus::HES5 at any point between 20-50μms away from the ventricle 531 
indicating that cells can make the cell fate decision at any point along the apical-532 
basal dimension of the progenitor zone. Though we could not resolve the differences 533 
between clusters 1 and 2, and clusters 3 and 4, our findings contrast with the 534 
schematic view that cell fate is controlled deterministically at global tissue level 535 
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through signalling gradients. Together with the finding that more cells show 536 
oscillations in a dissociated culture, we suggest that NPCs make stochastic fate 537 
decisions through a complex and yet unresolved integration between global and local 538 
cell-cell signalling.  539 
Our findings highlight the importance of integrating gene expression dynamics with 540 
spatio-temporal cell behavior to understand cell state transitions in real time in a 541 
multicellular tissue.  542 
 543 
 544 
Methods  545 
Animal models 546 
Animal (Mus musculus) experiments were performed under UK Home Office project 547 
licenses (PPL70/8858) within the conditions of the Animal (Scientific Procedures) Act 548 
1986. Animals were only handled by personal license holders. Venus::HES5 knock-in 549 
mice (ICR.Cg-Hes5<tm1(venus)Imayo>)9 were obtained from Riken Biological 550 
Resource Centre, Japan and mated with CD-1 mice for 1 generation before being 551 
maintained as an in-bred homozygous line. In these mice the mVenus fluorescent 552 
protein is fused to the N-terminus of endogenous HES5. R26R-H2B::mCherry mice56 553 
were obtained as frozen embryos from Riken Centre for Life Science Technologies, 554 
Japan and C57Bl6 mice were used as surrogates. Sox1Cre:ERT2 mice 555 
(Sox1tm3(cre/ERT2)Vep57 were obtained from James Briscoe with the permission of 556 
Robin Lovell-Badge. Sox1Cre:ERT2 (NIMR:Parkes background) and R26R-557 
H2B::mCherry (C57Bl6 background) were crossed to generate a double transgenic 558 
line (mixed background) homozygous for R26R-H2B::mCherry and heterozygous for 559 
Sox1Cre:ERT2. 560 
Embryo slicing 561 
Homozygous Venus::HES5 knock-in females were mated with R26R-H2B::mCherry 562 
Sox1Cre:ERT2 males and E0.5 was considered as midday on the day a plug was 563 
detected. Intra-peritoneal injection of pregnant females with 2.5 mg Tamoxifen 564 
(Sigma) was performed 18 hours prior to embryo dissection.  Whole embryos were 565 
screened for H2B::mCherry expression using Fluar 10x/0.5 objective on a Zeiss 566 
LSM880 confocal microscope and the trunks of positive embryos were embedded in 567 
4% low-gelling temperature agarose (Sigma) containing 5mg/ml glucose (Sigma). 568 
200μm transverse slices of the trunk around the forelimb region were obtained with 569 
the Leica VT1000S vibratome and released from the agarose. Embryo and slice 570 
manipulation was performed in phenol-red free L-15 media (ThermoFisher Scientific) 571 
on ice and the vibratome slicing was performed in chilled 1xPBS (ThermoFisher 572 
Scientific).  573 
Fluorescence Correlation Spectroscopy  574 
E10.5 transverse spinal cord slices heterozygous or homozygous for Venus::HES5 575 
were stained on ice for 1.5 hours with 50μM Draq5 (ThermoFisher Scientific) diluted 576 
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in phenol-red free L-15 (ThermoFisher Scientific) media. Fluorescence Correlation 577 
Spectroscopy (FCS) experiments and snapshot images of whole spinal cord were 578 
carried out using a Zeiss LSM880 microscope with a C-Apochromat 40x 1.2 NA 579 
water objective on slices placed directly on a glass-bottomed dish (Greiner BioOne) 580 
kept at 37°C and 5%CO2. FCS signals were collected inside single nuclei in either 581 
the ventral region alone or both dorsal and ventral regions for tissue experiments. 582 
Venus (EYFP) fluorescence was excited with 514 nm laser light and emission 583 
collected between 517 and 570nm. Data from individual cell nuclei was collected 584 
using 5 x 2 s runs at 0.15 to 0.3% laser power which gave <10% bleaching and a 585 
suitable count rate ~1 kHZ counts per molecule (CPM). To obtain molecule number, 586 
autocorrelation curves were fit to a two-component diffusion model with triplet state 587 
using the Levenberg-Marquardt algorithm in MATLAB optimization toolbox with initial 588 
conditions assuming a ‘fast’ diffusion component 10x faster than the ‘slow’ 589 
component58. Measurements collected from cells exhibiting large spikes/drops in 590 
count rate or with low CPM (<0.5 kHz), high triplet state (>50%), or high bleaching 591 
(>10%) were excluded from the final results. Number and brightness analysis of the 592 
count rate59 showed a high correlation with molecule number obtained from 593 
autocorrelation curve fitting. The effective confocal volume had been previously 594 
determined to be 0.57fL ± 11 fL (mean with S.D.) using Rhodamine 6G with known 595 
diffusion constant of 400 μm2 s-1 allowing conversion from molecule number to 596 
concentration60. Single-cell data of number of molecules in the cell nucleus was 597 
obtained by adjusting concentration to the average volumetric ratio between nuclear 598 
volume and confocal volume. Mean nuclear volume of 523 fL was estimated using 599 
H2BmCherry intensity and 3D reconstruction from z-stack images in Imaris 600 
(Bitplane).  601 
 602 
Generating a quantitative expression map  603 
Individual Draq5+ nuclei in a tile-scan image of a transverse slice of the whole E10.5 604 
spinal cord were manually segmented as ellipses using ImageJ and background 605 
Venus::HES5 fluorescence (measured via an ROI drawn outside of the cells) was 606 
subtracted. A quantile-quantile plot was generated for the distribution of nuclear 607 
Venus::HES5 intensities from manual segmentation of a single image and the 608 
distribution of nuclear Venus::HES5 concentrations from FCS of cells throughout the 609 
E10.5 spinal cord from multiple slices and experiments. Linear regression was used 610 
to generate a calibration curve between Venus::HES5 intensity and Venus::HES5 611 
concentration over the middle 90% of the range. The gradient of the line was used as 612 
a scaling factor and applied to the pixel intensity values in the segmented image to 613 
transform intensity to concentration. 614 
Analysis of variability in Venus::HES5 in snapshot images 615 
The centroids of the manually segmented cells from a quantitative expression map 616 
were used to measure distance from the ventricle and perpendicular to the D/V axis. 617 
Neighbours were ranked based on distance from the centroid of the cell of interest 618 
and the nearest neighbours were classified as the cells in the first rank 619 
(Supplementary Fig. 1n). Coefficient of variation of Venus::HES5 intensity was 620 
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measured by manual segmentation of Draq-5 stained transverse slices of whole 621 
E10.5 spinal cord in ImageJ. 622 
Embryo slice culture and live imaging 623 
E10.5 spinal cord slices for live timelapse microscopy were placed on a 12mm 624 
Millicell cell culture insert (MerckMillipore) in a 35mm glass-bottomed dish (Greiner 625 
BioOne) incubated at 37°C and 5%CO2. The legs of the cell culture insert were 626 
sanded down to decrease the distance from the glass to the tissue. Primary neural 627 
stem cells dissociated from E10.5-E11.5 Venus::HES5 spinal cords were maintained 628 
as a line for up to 10 passages and plated in 35mm glass-bottomed dish (Greiner 629 
BioOne) for live imaging. 1.5mls of DMEM F-12 (ThermoFisher Scientific) media 630 
containing 4.5mg/ml glucose, 1x MEM non-essential amino acids (ThermoFisher 631 
Scientific), 120ug/ml Bovine Album Fraction V (ThermoFisher Scientific), 55μM 2-632 
mercaptoethanol, 1x GlutaMAX (ThermoFisher Scientific), 0.5x B27 and 0.5x N2 was 633 
added. Movies were acquired using Zeiss LSM880 microscope and GaAsP 634 
detectors. For slice imaging a Plan-Apochromat 20x 0.8 NA objective with a pinhole 635 
of 5AU was used. 10 z-sections with 7.5 μm interval were acquired every 15 mins for 636 
18hrs. DMSO (Sigma) or 2μM DBZ (Tocris) was added to media immediately before 637 
imaging. For imaging dissociated cells a Fluar 40x 1.3 NA objective with a pinhole of 638 
6.5AU was used. 6 z-sections with 3.7 μm interval were acquired every 10 mins for 639 
24-48hrs. 640 
Image analysis and cell tracking 641 
Briefly, single cells were tracked using the H2B::mCherry channel. Background 642 
fluorescence as measured via an ROI drawn on a non-Venus::HES5 expressing 643 
region on the tissue was subtracted prior to analysing time-lapse intensity data. For 644 
cells in the ex-vivo slices single-cell Venus and mCherry expression were normalised 645 
to the whole tissue mean for the relevant channel to account for any possible 646 
photobleaching. For hierarchical clustering single-cell Venus::HES5 expression from 647 
12-hour tracks was standardized by subtracting the mean and dividing by the 648 
standard deviation of the single-cell signal. Time 0 refers to the start of the tracking 649 
and not necessarily the start of the movie.   650 
Single neural progenitor cells in E10.5 spinal cord slices were tracked in Imaris on 651 
the H2BmCherry channel using the ‘Spots’ and ‘Track over time’ function. Spot 652 
detection algorithm used background subtraction and tracking used the Brownian 653 
motion algorithm. All tracks were manually curated to ensure accurate single-cell 654 
tracking. A reference frame was applied to the movie along the dorso-ventral and 655 
apico-basal axes of the spinal cord to allow the distance from the ventricle to be 656 
calculated. To account for any photobleaching and allow comparison of intensities 657 
between movies the mean intensity of mCherry and Venus in each spot was 658 
normalised to the mean intensity of mCherry or Venus in the whole tissue. The whole 659 
tissue volume was tracked using the ‘Surfaces’ and ‘Track over time’ function. 660 
There was no correlation in Venus::HES5 and H2BmCherry expression suggesting 661 
the Venus::HES5 dynamics were not a result of global changes in transcription or 662 
translation in the cell or microscope anomalies (Supplementary Fig. 3a-d). We also 663 
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investigated the relationship between Venus::HES5 and z-position in the tissue 664 
(Supplementary Fig. 3e-h). As expected from imaging through tissue there was a 665 
small negative correlation (r = -0.24) between Venus::HES5 intensity and z-position 666 
when all cells and time-points were plotted (Supplementary Fig. 3f). However the 667 
range of z-positions in a single cell 12-hour track was rarely greater than 25μm, 668 
therefore it is unlikely the fluctuations and oscillations in Venus::HES5 are a result in 669 
changes in z-position (Supplementary Fig. 3g). Further at the single-cell level there is 670 
no difference in the correlation coefficient between z-position and Venus::HES5 671 
intensity when comparing oscillatory and non-oscillatory cells (Supplementary Fig. 672 
3h).  673 
To compare levels of Venus::HES5 expression between nuclei and movies the effect 674 
of increased light scattering with increasing depth of tissue was corrected to the initial 675 
z-position of the nuclei in the tissue. This was only performed when a comparison of 676 
absolute levels within the movies was required.  For each movie, a plot of single cell 677 
z-depth in the tissue vs single cell Venus::HES5 intensity was performed for all data 678 
points (similar to Supplementary Fig. 3f). Linear regression using least squares was 679 
performed to find the slope and y-intercept of the relationship between z-depth and 680 
Venus::HES5 intensity. For the initial time point the Venus::HES5 intensity was then 681 
corrected as if the cell was at z-position 0 by multiplying the slope of the z vs 682 
intensity relationship with the initial z-position and adding this value to the observed 683 
Venus::HES5 intensity. This value was then added to the Venus::HES5 intensity at 684 
all subsequent timepoints. 685 
 686 
Hierarchical clustering 687 
Prior to analysis, timeseries of single cell Venus::HES5 expression were normalised 688 
to tissue mean to account for bleaching per independent experiment and in addition 689 
standardised (z-score calculation) by subtracting the mean of the timeseries from 690 
each timepoint and dividing by the standard deviation of the timeseries. 691 
Standardising the data enables clustering on relative expression changes rather than 692 
absolute expression levels. Cells were aligned to all start at time 0, which refers to 693 
the start of the tracking rather than the start of the movie. Standardized single cell 694 
timeseries were then subject to hierarchical clustering using Euclidean distance and 695 
Ward’s linkage in RStudio (R Project). Experiments were clustered separately and 696 
each clustergram independently identified 4 clusters per experiment. The elbow 697 
method to look at the variance explained as a function of number of clusters (nbclust 698 
package, R), suggested 4-6 clusters as the optimal cluster number however 5 and 6 699 
clusters were not favoured by silhouette method (nbclust package, R) so we chose 4 700 
clusters. Cluster relationships varied between experiments thus for annotation 701 
between experiments corresponding clusters labels were determined by 1. 702 
observation of mean Venus::HES5 expression over time per cluster and 2. 703 
calculating average single-cell coefficient of variation (COV) in Venus::HES5 over 704 
time for each cluster and comparing to results of clustering experiment 1 705 
(Supplementary Fig. 4b). Thus, four clusters with the same mean Venus::HES5 706 
expression dynamics and COV profile are reproducibly identified in each experiment. 707 
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For DBZ-treated cells, data could not be corrected for photobleaching since 708 
Venus::HES5 downregulation is induced at tissue level causing a significant drop in 709 
tissue mean and masking effects from bleaching. Prior to analysis both DMSO and 710 
DBZ timeseries were standardised by z-scoring. To enable comparison between 711 
DBZ-treated and negative control DMSO-treated cells, experimental data from both 712 
treatment conditions were clustered together (Fig. 4d) as well as clustering DMSO 713 
independently of DBZ (Supplementary Fig. 6) yielding similar cluster profiles to 714 
untreated cells (Supplementary Fig. 6f,g).  715 
Estimation of cell-cycle phases 716 
Cell cycle phases were inferred based on position and trajectories of single nuclei 717 
over time. Nuclei were classified as in G1 if moving basally, following division, or if 718 
they maintained a basal position for multiple hours. Nuclei were classified as in S if 719 
they were in a basal position before moving apically and dividing. Similarly nuclei 720 
were classified as in G2 if they moved apically and divided. Cells were classified as 721 
undergoing mitosis if the H2B::mCherry signal was observed to duplicate. Multiple 722 
cell-cycle phases were attributed to each cell and all phases used to calculate a 723 
percentage profiles. 724 
Analysis of long-term trends in Venus::HES5 expression  725 
For 4, 8, 12, 14.25 and 17.25 hour time windows the coefficient of variation (standard 726 
deviation/mean x100) of all the normalised Venus::HES5 intensity values for a single 727 
cell in the time window was calculated. The shoulder point of Venus::HES5 was 728 
defined as a turning point in the signal that lead to a decrease of greater than 50% of 729 
the signal. 730 
Immunofluorescent staining  731 
Trunks of E10.5 embryos for cryo-sectioning were fixed in 4% PFA for 1 hour at 4oC, 732 
followed by 3 quick washes with 1xPBS and 1 longer wash for 1 hour at 4oC. 733 
Embryos were equilibrated overnight in 30% sucrose (Sigma) at 4oC before mounting 734 
in Tissue-Tek OCT (Sakura) in cryomoulds and freezing at -80oC. 12μm sections 735 
were cut on Leica CM3050S cryostat. E10.5 spinal cord slices cultured on Millicell 736 
inserts were fixed in 4% PFA for 4 hours. For staining, tissue and sections were 737 
washed in PBS followed by permeabilisation in PBS 0.2% Triton X-100 (Sigma) and 738 
blocking with PBS 0.05% Tween20 (Sigma) + 5% BSA (Sigma). Primary and 739 
secondary antibodies were diluted in PBS 0.05% Tween20 + 5% BSA. Tissue was 740 
incubated with primary antibodies overnight at 4°C, then washed three times for 5–10 741 
minutes in PBS 0.05% Tween20, incubated with secondary antibodies and DAPI 742 
(Sigma) for 4 hours at room temperature, and washed again three times in PBS-T. 743 
Sections were mounted using mowiol 4-88 (Sigma). Primary antibodies used were 744 
rabbit anti-SOX2 (ab97959, 1:200), mouse anti-NeuN (Merck MAB377, 1:100) 745 
mouse anti-NKX2.2 (74.5A5, Developmental Studies Hybridoma Bank, 1:10), mouse 746 
anti-PAX7 (Developmental Studies Hybridoma Bank, 1:10), rabbit anti-Olig2 (EMD 747 
Millipore AB9610, 1:200), mouse anti-Isl1/2 (Developmental Studies Hybridoma 748 
Bank, 1:100) and rabbit anti-β3-tubulin (Cell Signaling Technology, 5568S 1:200). 749 
Cell culture 750 
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Primary NS cells were isolated from dissected spinal cords of E10.5-11.5 embryos 751 
from Venus::HES5 knock-in mice and cultured in DMEM/F-12 containing 4.5mg/ml 752 
glucose, 1x MEM non-essential amino acids (ThermoFisher Scientific), 120ug/ml 753 
Bovine Album Fraction V (ThermoFisher Scientific), 55μM 2-mercaptoethanol, 1x 754 
GlutaMAX (ThermoFisher Scientific), 0.5x B27 and 0.5x N2. NS-E cells were a gift 755 
from Jennifer Nichols (Cambridge Stem Cell Institute, UK). 756 
Half-life experiments 757 
Protein half-life was obtained by transfection of 3xFlag-HES5 and 3xFlag-758 
Venus::HES5 in to NS-E cells with Lipofectamine 3000 (ThermoFisher Scientific) as 759 
per manufacturers’ instructions. 24 hours after transfection, cells were treated with 760 
10μM cycloheximide (Sigma) and at 0, 15, 30, 60, 120, and 240 mins after treatment 761 
lysed with. Western blots were performed using 4-20% Tris-glycine acrylamide gels 762 
(NuSep), Whatman Protran nitrocellulose membrane (Sigma) and developed with 763 
Pierce ECL substrate (ThermoFisher Scientific). Antibodies used were anti-HES5 764 
[EPR15578] (Abcam, ab194111) and anti-alpha-tubulin (clone DM1A Sigma T9026). 765 
RNA half-life experiments were obtained by 10μM actinomycin D (ThermoFisher, 766 
Scientific) treatment of primary heterozygous Venus::HES5 and primary wild-type 767 
spinal cord NS cells. Samples were taken at 0, 15, 30, 45, 60, 80, 100, 120 mins 768 
after treatment and RNA prepared using RNAeasy kit (Qiagen) with DNAse 769 
treatment as per manufacturers instructions. cDNA was prepared using Superscript 770 
III (Invitrogen) as per manufacturers’ instructions and qPCR for Venus, HES5 and 771 
GAPDH was performed with Taqman (ThermoFisher, Scientific, UK) gene 772 
expression assays. 773 
 774 
Statistical testing 775 
Statistical tests were performed in GraphPad Prism 7. Data was tested for normality 776 
with D’Agostino-Pearson test. The relevant parametric or non-parametric test was 777 
then performed. If necessary outlier removal was performed using ROUT method 778 
(GraphPad). Coefficient of variation is defined as standard deviation (SD) over the 779 
mean.  780 
Stacked bar plots and discrete scatter plots show mean or mean±SD where multiple 781 
independent experiments are analysed. Statistical significance between 2 datasets 782 
was tested with either Student t-test (parametric) or Mann-Whitney test (non-783 
parametric). Statistical significance (p<0.05) for 2+ datasets was tested by Kruskall-784 
Wallis with Dunn’s multiple comparison correction. All tests were 2-sided. Multiple 785 
comparison testing involved comparing all pairs of data columns. Correlations were 786 
analysed using Spearman rank correlation coefficient. Sample sizes, experiment 787 
numbers, p values<0.05 and correlation coefficients are reported in each figure 788 
legend.  789 
Detection of oscillations using Gaussian processes 790 
We adapted the statistical approach developed by Phillips et al.43 to analyse 791 
timeseries of Venus::HES5 in single cells tracked in 3D fluorescence imaging. Data 792 
was de-trended to remove long term behaviour such as down-regulation and to 793 
recover the oscillatory signal with zero mean. We used maximum likelihood 794 
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estimation to fit the de-trended data timeseries with two competing models: a 795 
fluctuating aperiodic one (null model) and an oscillatory one (alternative model). We 796 
used the log-likelihood ratio statistic to compare the likelihood of data being 797 
oscillatory or non-oscillatory and determined the oscillators based on a false 798 
discovery rate of 3% independently per experiment. The custom algorithms and 799 
routines were implemented and tested in MATLAB R2015a and are using the GPML 800 
toolbox61. 801 
Gaussian processes (GPs) background.   802 
GP inference is a probabilistic modelling technique that involves fitting a time-series 803 
signal ݕ(ݐ) in terms of a mean function, ݉(ݐ) describing the moving average of signal 804 
with respect to time and a covariance function, ݇(߬) describing how the signal varies 805 
around the mean with respect to time 806 
݉(ݐ) = ॱሾݕ(ݐ)ሿ ,
݇(߬) = ॱൣ(ݕ(ݐ) − ݉(ݐ))൫ݕ൫ݐ′൯ − ݉(ݐ′)൯൧ , 
where the covariance function for this process varies with  ߬ = หݐ − ݐ′ห , representing 807 
the time interval between any pair of time points (ݐ, ݐ′). The covariance function is 808 
typically represented by a parameterised function that encapsulates modelling 809 
assumptions. The GP provides a generative model for the data, i.e. for known mean 810 
and covariance functions synthetic data may be generated by sampling from the 811 
multivariate normal distribution ࣡࣪(݉, ݇)  evaluated at the times where data are 812 
collected. The likelihood function, which is the probability of the observed data under 813 
the model, is exactly tractable making inference and parameter estimation possible.  814 
Detrending single cell expression timeseries  815 
Single cell protein expression timeseries contain information about dynamics at long 816 
timescales (above 10-12hrs) as well as dynamics at short timescales (2-5hrs). To 817 
account for this, we first model the long-term behaviour (i.e. mean function) using a 818 
squared covariance function:  819 
ܭ௦௘(߬) = ߪ௦௘ exp(−ߙ௦௘߬ଶ) .  820 
This allows us to determine the mean function ݕ௦௘(ݐ)  ∈ ࣡࣪(0, ݇ௌா) and extract the 821 
detrended dynamics by: ݕௗ(ݐ) = ݕ(ݐ) − ݕ௦௘(ݐ) . We used a lengthscale ߙ௦௘ 822 
corresponding to 10hrs to remove long term dynamics while preserving short 823 
periodicity dynamics. Next we modelled the detrended data with zero mean using GP 824 
and two competing covariance models each with characteristic parameters inferred 825 
from the data. These models are described in the following section. 826 
Oscillatory and Non-Oscillatory Covariance models 827 
 The detrended timeseries can be oscillatory or non-oscillatory (examples in 828 
Supplementary Fig. 8a and Supplementary Fig. 8b respectively). To account for this, 829 
two covariance models are used, namely:  830 
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ܭை௎(߬) = ߪை௎ exp(−ߙ߬),
ܭை௎௢௦௖(߬) = ߪை௎௢௦௖ exp(−ߙ߬) cos(ߚ߬) , 
 where ܭை௎  is a standard Ornstein-Uhlenbeck (OU) covariance function, which 831 
models aperiodic stochastic fluctuations, while  ܭை௎௢௦௖ is a oscillatory OU covariance 832 
function, which models periodic stochastic timeseries. The parameters determining 833 
these models are:  834 
• signal variance ߪை௎, ߪை௎௢௦௖ ; related to signal amplitude by ݕௗതതത = 2√ߪ; 835 
• lengthscale ߙ  which represents the rate at which correlations between 836 
subsequent peaks decay over time ( see also discussion in Prior Distribution 837 
on Lengthscale); 838 
• frequency ߚ; related to periodicity by ܶ = 2ߨ ߚൗ  . 839 
In the following section, we discuss how the probability of the observed data given 840 
the periodic model is affected by technical noise and we introduce a global 841 
calibration technique that accounts for this.  842 
Global Calibration of Technical Noise 843 
The fluorescent detrended signal from an oscillatory cell contains periodic variations 844 
over time (modelled by the stochastic and periodic covariance model ܭை௎௢௦௖) as well 845 
as additive technical noise: ݕௗ∗ (ݐ) = ݕௗ(ݐ) + ߝ , where ߝ denotes white noise of zero 846 
mean and variance ߪ௡. The technical noise parameter ߪ௡ is unknown and needs to 847 
be estimated.  848 
Phillips et al.43 use an experimental estimation of technical noise where signal 849 
collected from empty areas of the cell culture dish (background) is used to 850 
approximate signal detection noise in bioluminescence imaging. Here we use a 851 
fluorescence reporter which suffers from variability of noise from the detector (also 852 
present in bioluminescence) and auto-fluorescence produced by the cells thus 853 
showing an overall increased noise level in cells than background. 854 
To account for this, we propose a different strategy to estimate technical noise 855 
directly from the data by observing the relationship between likelihood and signal-to-856 
noise ratio, i.e. optimizing joint likelihood. The joint likelihood function describes the 857 
probability of observing all the data per experiment under a global model: 858 
maxఏ ைܲ௎௢௦௖  = ෑ ݌ை௎௢௦௖
௜ (
ே
௜ୀଵ
ݕௗ௜,∗หݐ, ߠை௎௢௦௖௚௟௢௕௔௟൯, 
where ߠை௎௢௦௖௚௟௢௕௔௟ = (ߙ௚௟௢௕௔௟, ߚ௚௟௢௕௔௟, ߪை௎௢௦௖௚௟௢௕௔௟) represents the global hyperparameters and 859 
݌ை௎௢௦௖௜   denote individual likelihood functions; and N is the total number of cells in 860 
each dataset. An equivalent and more convenient optimisation is to maximize the 861 
joint log-likelihood function: 862 
maxఏ log ைܲ௎௢௦௖  = ෍ log ݌ை௎௢௦௖
௜ (
ே
௜ୀଵ
ݕௗ௜,∗หݐ, ߠை௎௢௦௖௚௟௢௕௔௟൯,  
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where the cell-specific log-likelihood functions are: 863 
log ݌ை௎௢௦௖௜ ൫ݕௗ௜,∗หݐ, ߠை௎௢௦௖௚௟௢௕௔௟)   = −
1
2 logหܭை௎௢௦௖
௜,∗ ห − 12 ݕௗ
௜,∗்݅݊ݒ൫ܭை௨௢௦௖௜,∗ ൯ݕௗ௜,∗ −
݊௜
2 log(2ߨ) , 
with ݊௜ representing the number of time-points in each trace and  ܭை௎,ை௨௢௦௖∗  denoting 864 
the cell-specific OUosc covariance models with technical noise: 865 
ܭை௨௢௦௖௜,∗ (߬) = ܭை௎௢௦௖௜ (߬) + ߪ௡௚௟௢௕௔௟ܫ. 866 
The global estimation of ܴܵܰ = ߪை௎௢௦௖
௚௟௢௕௔௟
ߪ௡௚௟௢௕௔௟
൘  indicates that the joint log-likelihood 867 
function is low (indicating a poor model) when the signal is assumed to have high 868 
signal-to-noise and is highest (indicating an optimal model) for noise levels from 10-869 
15% (Supplementary Fig. 8c). Since the joint log-likelihood levels are not improved 870 
for noise above 10%, we conclude that the characteristic level of noise at maximum 871 
joint log-likelihood for the 3D tissue data is approximately 10%. 872 
For single cell parameter estimation (described in the next section), we calibrated the 873 
technical noise level expressed in fluorescent intensity units at the global level and 874 
re-estimated the remaining parameters for each cell. In this way we ensure that cells 875 
have the same (global) amount of technical noise variance and that the remaining 876 
variability comes from the true signal. This generates a fit that is robust and avoids 877 
over-fitting. In the following, we describe the parameter estimation procedure: 878 
Maximum Likelihood Estimation and Log-Likelihood Ratio  879 
Using the global calibrated level of technical noise, we further optimise GP 880 
covariance model parameters for single cell timeseries.  Since we do not know a 881 
priori if single cell traces are periodic or not, we estimate parameters for both OU and 882 
OUosc models by estimating the optimal hyperparameters ߠை௎௜ = (ߙ௜, ߪை௎௜ )  and  883 
ߠை௎௢௦௖௜ = (ߙ௜, ߚ௜, ߪை௎௢௦௖௜ )  respectively. These parameters maximising the log- 884 
likelihood function : 885 
max
ఏ೔
log ݌ை௎,ை௨௢௦௖௜ ൫ݕௗ௜,∗หݐ, ߠை௎/ை௎௢௦௖௜ )   
= − 12 logหܭை௎/ை௎௢௦௖
௜,∗ ห − 12 ݕௗ
்݅݊ݒ൫ܭை௎/ை௨௢௦௖௜,∗ ൯ݕௗ −
݊௜
2 log(2ߨ) . 
The likelihood value of the periodic model does not directly indicate if the data is 886 
oscillatory or non-oscillatory since OUosc can also fit non-oscillatory data (OUosc 887 
becomes OU for ߚ → 0 ). However, a higher likelihood for OUosc compared to 888 
likelihood of OU indicates increased probability of the signal to be oscillatory. To 889 
quantify the probability for the single cell data to be oscillatory, we use the log-890 
likelihood ratio statistic: 891 
ܮܮܴ = 2 log ݌ை௎௢௦௖݌ை௎ = 2ܮܮை௎௢௦௖ − 2ܮܮை௎, 
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where  ܮܮை௎ = log ݌ை௎(ݕௗ∗|ݐ, ߠை௎ெ௅ா)  and ܮܮை௎௢௦௖ = log ݌ை௎௢௦௖(ݕௗ∗|ݐ, ߠை௎௢௦௖ெ௅ா ) . To 892 
account for effects caused by length of each trace  ݊௜, the following normalisation 893 
was used ܮܮܴ௜ = ܮܮܴ௜ ݊௜ൗ . 894 
Detection of Oscillators by False Discovery Rate  895 
In order to classify cells into oscillatory and non-oscillatory, we identify statistically 896 
significant LLR scores by comparing to LLR scores obtained from a null (non-897 
oscillatory) distribution62 and controlling for the false discovery rate (FDR) per 898 
experiment. We obtain a synthetic null distribution using the generative OU (non-899 
oscillatory) models that have been fitted to data. This allows generating a large 900 
number of synthetic traces that are non-oscillatory. To find statistically significant 901 
oscillators we set FDR to 3%. Controlling the FDR ensures that false positives are 902 
very unlikely to be considered oscillatory (less than 1 in 33 cells analysed) and an 903 
example from data is shown in Supplementary Fig. 8d. In combination with GP 904 
models used in this study, the FDR technique63 has been shown to outperform 905 
standard Lomb-Scargle periodogram (for detection of oscillations by frequency 906 
analysis) in terms of specificity and sensitivity43.  907 
 908 
Prior Distribution on Lengthscale 909 
Lengthscale is a parameter of the covariance model that describes the rate at which 910 
subsequent peaks in the oscillatory signal become uncorrelated over time. In 911 
practice, we found that estimating lengthscale as a free parameter can lead to ߙ → 0 912 
for some of the cells (Supplementary Fig. 8e-panel 1 and insert). This possibility is 913 
unrealistic since it would imply correlations in the signal never decay over time. This 914 
vulnerability is likely to be caused by issues with the length of the data tracks which 915 
contain few samples (approximately 45 data points per cell acquired at 15min 916 
intervals) thus affecting the maximum likelihood technique.  917 
To address this, we estimated lengthscale globally using the same technique 918 
described in Global calibration of technical noise section and used this to initialize the 919 
single cell parameter inference. In addition, we introduced a prior on the lengthscale 920 
that contains the global estimated value. The prior is defined as  921 
SmoothBox1 (SB1) (existing in GPML toolbox) that has a sigmoidal expression 922 
around a lower bound, ݈ and an upper bound, ܮ: 923 
ܵܤ1(ߙ) = ݏ݅݃݉(ߟ(ݔ − ݈)(1 − ݏ݅݃݉൫ߟ(ݔ − ܮ)൯,
ݏ݅݃݉(ݖ) = 1 1 + exp (−ݖ)ൗ ,
 
where ߟ is a parameter that controls the shape, with higher values leading to a box 924 
appearance. The shape of the prior affects the posterior distribution of lengthscales 925 
that is estimated from the data. Although both a restrictive, box-shaped prior and 926 
relaxed, smooth prior help prevent ߙ → 0 (Supplementary Fig. 8e-panels 2-3), the 927 
restrictive choice significantly alters the shape of the distribution at either bounds 928 
(Supplementary Fig. 8e-panel 2). By using a relaxed prior (Supplementary Fig. 8e-929 
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panel 3), we obtain a posterior distribution centered at the global estimate while still 930 
correcting for unwanted low values.  931 
Hilbert Reconstruction and Peak-to-Trough Fold Changes  932 
We designed custom routines for instantaneous amplitude and phase reconstruction 933 
using the Hilbert transform and we used this to measure absolute peak-to-trough fold 934 
changes in signal over time. The Hilbert transform is used to reconstruct the 935 
instantaneous characteristics of the signal based on the analytic signal ݖௗ(ݐ) 64. The 936 
analytic signal consists of a real part identical to the data: ܴ݁ ݖௗ(ݐ) = ݕௗ(ݐ); and an 937 
imaginary part representing the data with a ߨ/2  phase shift, where phase shift 938 
denotes a difference in the peaks of two waves. It is generally assumed that, ܴ݁ ݖௗ(ݐ) 939 
is proportional to a cosine wave, thus ܫ݉ ݖௗ(ݐ) will be proportional to a sine wave or 940 
viceversa. The analytic signal relates to instantaneous amplitude ܣ and phase ߮ by: 941 
ݖௗ = ܣ exp(݅߮). This leads to the following expression for amplitude and phase: 942 
ܣ = ඥܴ݁ ݖௗ(ݐ)ଶ + ܫ݉ ݖௗ(ݐ)ଶ,
߮ = ∢൫ܴ݁ ݖௗ(ݐ), ܫ݉ ݖௗ(ݐ)൯.
 
We applied the Hilbert transform implemented as hilbert.m in MATLAB on the fitted 943 
model obtained from analysing the detrended oscillatory data with ܭை௎௢௦௖. Amplitude 944 
is detected in the detrended data and translated back to real intensity units (or 945 
relative units where appropriate) by summation with the long-term trend 946 
(Supplementary Fig. 8f). The reconstructed phase (Supplementary Fig. 8g) has a 947 
seesaw appearance that is characteristic of oscillatory data and indicative of a phase 948 
reset at the end of a complete period. Thus phase contains information on periodicity 949 
and we confirmed that periods estimated using GP agreed well with average 950 
reconstructed Hilbert periods (data not shown). In addition, the times at which the 951 
phase angle crosses the zero-level corresponds to peaks and troughs in the 952 
oscillatory signal. We used this property to identify peaks (ascending zero-crossing of 953 
phase) and troughs (descending zero-crossing of phase) in the real signal and 954 
generate absolute fold changes in amplitude by pairing a peak with the nearest 955 
trough and expressing the peak-to-trough intensity ratio for each pair. We report 956 
amplitude fold changes in the complete signal (containing the long-term trend and 957 
named peak:trough fold changes in figures and main text) either as maximum fold 958 
change or average fold change as indicated in figure legends.  959 
 960 
Stochastic model of HES5 expression dynamics.  961 
We modelled protein expression dynamics emerging from transcriptional 962 
autorepression and delay using an established mathematical model46. The model 963 
simulates changes of mRNA and protein number in a cell over time by considering 964 
the effects of transcription, translation, and degradation of protein and mRNA (Fig. 965 
6a). The model includes effects of a transcriptional delay, representing that it takes a 966 
finite amount of time for mRNA to be produced and transported out of the nucleus for 967 
translation. The model further includes the effect of genetic auto-repression, i.e. we 968 
assume that high abundance of HES5 can inhibit its own transcription. In order to be 969 
able to describe both aperiodic and oscillatory dynamics we account for intrinsic 970 
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stochasticity that is typically associated with rate-processes44,49. The model is 971 
implemented using delayed Chemical Langevin equations of the form65,66 972 
݀ܯ
݀ݐ = −ߤ௠ܯ(ݐ) + ߙ௠ܩ൫ܲ(ݐ − ߬)൯ + ටߤ௠ܯ(ݐ) + ߙ௠ܩ൫ܲ(ݐ − ߬)൯ߦ௠(ݐ), 
݀ܲ
݀ݐ = −ߤ௣ܲ(ݐ) + ߙ௣ܯ(ݐ) + ටߤ௣ܲ(ݐ) + ߙ௣ܯ(ݐ)ߦ௣(ݐ),  
where ܯ(ݐ)  denotes the number of mRNA molecules in one cell at time ݐ , ܲ(ݐ) 973 
denotes the number of HES5 protein molecules, and ߬  represents transcriptional 974 
delay, i.e. the average time that is required for individual mRNA molecules to be 975 
transcribed and transported to the ribosome. The parameters ߤ௠, ߤ௣, ߙ௠ and ߙ௣ are 976 
rate constants denoting the rates of mRNA degradation, protein degradation, basal 977 
transcription in the absence of protein, and protein translation, respectively. The rate 978 
of transcription in the model is modulated in dependence of HES5 protein ܲ at time 979 
ݐ − ߬ by the Hill function65 980 
ܩ൫ܲ(ݐ − ߬)൯ = 11 + (ܲ(ݐ − ߬)/ ଴ܲ)௡. 
The variables ߦ௠  and ߦ௣  denote Gaussian white noise, which is characterised by 981 
delta-distributed autocorrelations50, 982 
⟨ߦ௠(ݐଵ)ߦ௠(ݐଶ)⟩ = ߜ(ݐଵ − ݐଶ), 
ൻߦ௣(ݐଵ)ߦ௣(ݐଶ)ൿ = ߜ(ݐଵ − ݐଶ), 
⟨ߦ௠(ݐଵ)ߦ௣(ݐଶ)⟩ = 0. 
Note that Chemical Langevin equations allow non-integer values for the molecule 983 
numbers of mRNA and Protein. 984 
Numerical implementation of the model  985 
We calculate summary statistics from the long-term trend of the model to enable 986 
model-data comparison. To investigate model behaviour at a unique combination of 987 
model parameters (in the following referred to as parameter point), we generate 988 
௣ܰ = 200 model traces at this parameter point and calculate averaged summary 989 
statistics from these traces. For each trace, the first ݐୣ୯ = 1000  minutes are 990 
discarded and the remaining ݐ୭ୠୱ = 7500  minutes are used for the evaluation of 991 
summary statistics. The equilibration time ݐୣ୯  is chosen such that that summary 992 
statistics do not depend on the initial condition. Initial conditions to evaluate the 993 
model at a given parameter point are ܯ୧୬ = 10  mRNA molecules, and ୧ܲ୬ = ଴ܲ 994 
protein molecules. We impose that no mRNA transcription events were initiated at 995 
negative times by inhibiting transcription in the model for ݐ < ߬. Specifying model 996 
behaviour for negative times is necessary when evaluating delay differential 997 
equations. Chemical Langevin equations were implemented numerically using an 998 
Euler-Maruyama scheme and a time step of ∆ݐ = 1 minute. All numerical simulation 999 
parameters are listed in Supplementary Table 1. 1000 
Coherence and other summary statistics 1001 
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To characterise the model behaviour at individual parameter points we collect the 1002 
following summary statistics: (i) the mean protein expression level 〈ܲ〉, (ii) the relative 1003 
standard deviation of protein expression ߪ௥,௉ = ߪ௉ / 〈ܲ〉 , where ߪ௉   denotes the 1004 
absolute standard deviation of protein expression, (iii) the coherence and (iv) the 1005 
mean observed period. Means and standard deviations of expression (i-ii) are 1006 
calculated across all traces at one parameter point and across all discretized 1007 
timesteps in the observation window. 1008 
In order to calculate the oscillation coherence in Fig. 6d-g we use Fourier transforms 1009 
of individual traces across the observation window, i.e  1010 
ܲ~(߱) = න ܲ(ݐ) expሼ−2ߨ݅߱ݐሽ ݀ݐ
௧೚್ೞ
௧ୀ଴
. 
We then use the obtained Fourier transforms to calculate the power spectrum of the 1011 
model at a parameter point, ݂(߱) = ⟨ܲ~(ݓ)ܲ~∗(ݓ)⟩ . Here, the asterisk  ∗  denotes 1012 
complex conjugation and the average is taken over all ௣ܰ simulated traces at one 1013 
parameter point. The discrete Fourier transform implemented in the Python numpy.fft 1014 
package is used, introduced by Cooley and Tukey67. In order to minimise the 1015 
influence of finite-size effects on the power spectrum we apply smoothing via a 1016 
Savitzky-Golay filter68 with polynomial order three and a filtering window of  1017 
0.001/min, which corresponds to seven discrete frequency values. The coherence is 1018 
then defined as ܥ = ܣ୫ୟ୶/ܣ୲୭୲  52,69, where ܣ୫ୟ୶  is the area under the power 1019 
spectrum in a 20-percent band centred at the frequency corresponding to the 1020 
maximum of the power spectrum, and ܣ୲୭୲ is the total area of the power spectrum. 1021 
Typically, coherence is low for non-oscillatory cells and high for oscillatory cells. In 1022 
Fig. 6h the linear noise approximation44 was used to calculate the power spectrum 1023 
analytically before extracting coherence values, which reduces computational 1024 
complexity. To calculate coherence values for the deterministic system65 (data shown 1025 
in Fig. 6i) we used bifurcation analysis70,71 to identify whether oscillatory solutions 1026 
exist at individual parameter points. If oscillatory solutions exist, the coherence at this 1027 
parameter point is one, otherwise it is zero. In Fig. 6h,i the mean posterior predicted 1028 
coherence values are plotted for varying degradation rates in the stochastic model 1029 
and the deterministic model, respectively.  1030 
In order to extract period values from simulated data that can be compared to our 1031 
experimental observations we applied the Hilbert transform technique (see also 1032 
Hilbert Reconstruction) to simulated traces. At each parameter point, we generate 1033 
one equilibrated trace of 12-hour duration, a similar observation window as the 1034 
experimental data. Period values are identified as time differences between 1035 
consecutive descending zero-crossings of the instantaneous phase, and the mean 1036 
period across the measurement interval is recorded. In Fig. 6b the posterior 1037 
predicted distribution of this mean period value is shown. The following section 1038 
describes how Bayesian posterior predictions are generated. 1039 
Parameter inference 1040 
In order to parameterise the model we use a combined approach of experimental 1041 
parameter measurements and Approximate Bayesian Computation (ABC)72,73. 1042 
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Specifically, we use experimentally measured values for the mRNA and protein 1043 
degradation rates, corresponding to half-life values of 30 and 90 minutes, 1044 
respectively (Supplementary Fig. 1). For the remaining, unknown, model parameters, 1045 
we apply ABC, which is a standard method to infer parameters of non-linear 1046 
stochastic models. ABC has the benefit of providing probability distributions for 1047 
parameters, rather than point-estimates which in turn enables the estimation of 1048 
parameter uncertainty, i.e. the uncertainty on the model parameters given the 1049 
observed data.  1050 
We use ABC to identify parameter combinations that can explain key aspects of 1051 
traces in clusters one and two. Specifically, we require the mean HES5 expression 1052 
level to fall within the experimentally observed range of 55000 to 65000 protein 1053 
molecules per cell (Supplementary Fig. 10a), and for which the standard deviation of 1054 
modelled traces lies above five percent (Supplementary Fig. 10b). We analyse model 1055 
predictions in Fig. 6 by investigating Bayesian posterior predictions, i.e. the 1056 
distribution of model predictions given the posterior distribution of model parameters. 1057 
When investigating the impact of parameter changes on model predictions in Fig. 6j, 1058 
we define a model prediction at a given parameter combination as aperiodic if (i) the 1059 
predicted oscillation coherence is below 0.1, or if (ii) the predicted period, as 1060 
identified by a peak in the power spectrum, is longer than 10 hours. We identify the 1061 
posterior parameter samples fulfilling this condition and record their total number as 1062 
௦ܰ௧௘௔ௗ௬ . Starting from these ௦ܰ௧௘௔ௗ௬  aperiodic parameter combinations we change 1063 
individual model parameters by 50% and count the number of parameter 1064 
combinations ௢ܰ௦௖ for which an individual parameter change leads to (iii) predicted 1065 
coherence values above 0.1, and (iv) period values below 5 hours. The likelihood of 1066 
an individual parameter change to induce oscillations in agreement with (i)-(iv) is 1067 
then defined ܮ௢௦௖  =  ௢ܰ௦௖/ ௦ܰ௧௘௔ௗ௬. We normalise the values of ܮ௢௦௖ to sum to a total 1068 
probability of one in Fig. 6j. In order to ensure an accurate estimate of the likelihood 1069 
values we increased the number of prior samples ௧ܰ௢௧ to 2,000,000 in Fig. 6j, which 1070 
ensured a sufficiently large ௦ܰ௧௘௔ௗ௬, with ௦ܰ௧௘௔ௗ௬ = 20872. 1071 
Background on Bayesian inference.  1072 
In Bayesian statistics, the joint probability distribution ݌(દ, ࡰ) of a parameter vector 1073 
(parameter point) દ and observed data vector ࡰ is used to calculate the posterior 1074 
distribution ݌(દ|ࡰ), the probability distribution of the parameters given the data. The 1075 
calculation of the posterior is achieved by applying Bayes' rule  1076 
݌(દ|ࡰ) = ݌(ࡰ|દ)݌(દ)݌(ࡰ) , 
where ݌(ࡰ|દ) represents the probability of ࡰ given દ, and is usually referred to as 1077 
the likelihood, and ݌(ࡰ) , the probability of observing the data, is the marginal 1078 
likelihood. The likelihood of the parameter ݌(દ) is referred to as the prior.  1079 
ABC can be used to estimate parameters of complex models for which the likelihood 1080 
is not analytically tractable. Here, we apply rejection-based ABC72, which 1081 
approximates the posterior through random sampling of parameters from the prior 1082 
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distribution and evaluating the model for each sample. Summary statistics are used 1083 
in order to compare the model with data. This is necessary since the modelled data 1084 
is high-dimensional: in our case it comprises the protein and mRNA numbers at each 1085 
simulated timepoint in ௣ܰ =200 simulated cells per parameter point. As detailed 1086 
above, we use the mean protein expression and the standard deviation of protein 1087 
expression as summary statistics for fitting. In rejection-based ABC, samples for 1088 
which the chosen summary statistics fall within an experimentally observed range are 1089 
accepted as samples of the posterior distribution, otherwise they are rejected. Here, 1090 
we generate ୲ܰ୭୲ = 200,000  samples from the prior distribution, providing us with 1091 
4,901 samples of the posterior distribution. The choice of prior distribution is 1092 
discussed in the following section. 1093 
Prior information on parameters.   1094 
When applying ABC it is necessary to define a prior probability ݌(દ) 73. This prior is 1095 
typically used to restrict inferred parameter combinations to biophysically realistic 1096 
values, by imposing uniform and uncorrelated distributions on each parameter. We 1097 
follow this approach by considering biophysical principles and literature values to 1098 
define marginal prior distributions on each parameter as detailed below and 1099 
summarised in Supplementary Table 2.     1100 
For the basal transcription rate ߙ௠ , we assume a logarithmically-uniform prior, 1101 
representing that we do not initially know the order of magnitude of this parameter. 1102 
We consider a maximal, biophysically possible transcription rate of 60 transcripts per 1103 
minute, which has previously been estimated74,75. We choose a lower bound of 0.1 1104 
transcripts per minute. This lower bound is chosen manually such that the prior 1105 
bounds lie outside the support of the posterior. An example experimental estimate of 1106 
a gene transcription rate is two transcripts per minute76. A genome-wide 1107 
quantification of transcription rate estimates in mouse fibroblast cells revealed a 1108 
distribution of transcription rates between 10ିଷand eight transcripts per minute77.  1109 
For the translation rate ߙ௣ , which represents the number of protein molecules 1110 
generated per mRNA molecule per time interval, we use a logarithmically-uniform 1111 
prior, similar to the prior in the basal transcription rate. We consider biophysical 1112 
principles to impose an upper boundary on the translation rate as follows: ribosomes 1113 
translate individual mRNA molecules with a speed of approximately six codons per 1114 
second78–80. The footprint of an individual ribosome is approximately ten 1115 
codons81.Thus individual ribosomes require approximately 1.6 seconds in order to 1116 
free the translation start site, which limits the maximal possible translation rate to 1117 
approximately 40 translation events per mRNA molecule per minute. We hence use 1118 
40/min as upper value for our prior on the translation rate, and the lower bound is 1119 
chosen to be 0.5/min, which is chosen sufficiently small to lie on the outside of the 1120 
support of the posterior. Genome-wide quantification of translation rate estimates 1121 
included values of 20 translation events per mRNA per minute and above77. 1122 
The repression threshold ଴ܲ  represents the amount of protein required to reduce 1123 
HES5 transcription by half. For the repression threshold we use a uniform prior 1124 
covering the range 0-120000. The upper bound is chosen as twice the value of the 1125 
experimentally observed number of protein molecules per cell (~60,000), which is 1126 
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sufficiently large to include parameter regimes corresponding to no genetic auto-1127 
repression. 1128 
The transcriptional delay ߬ corresponds to the time required to transcribe RNA and 1129 
move it out of the nucleus for translation. Previous estimates of this parameter for a 1130 
variety of genes varied between five and 40 minutes82, and typically assumed values 1131 
are around 20-30 minutes52,65. Based on these values we used a uniformly 1132 
distributed prior of five to 40 minutes. 1133 
The Hill coefficient ݊  describes the steepness of the auto-repression response. 1134 
Previously used values range between two and five44,52,65,83. Here, we use a uniform 1135 
prior in the range of two to six. Importantly, we do not consider values above ݊ = 6 1136 
since (i) the change in slope of ܩ decreases for increasing ݊, and (ii) high values of ݊ 1137 
correspond to steep, step-like, response curves, which are unrealistic. 1138 
Prediction of mean and variance correlation 1139 
 1140 
In order to estimate how mean and variance inter-depend in our model we obtained 1141 
Bayesian posterior predictions for mean HES5 expression and for its variance after 1142 
changing the repression threshold (P0), which we varied from 10% to 200% of its 1143 
original value in 10% intervals. For each relative change in the repression threshold 1144 
these Bayesian posterior predictions are probability distributions analogous to those 1145 
in Figure 6b and c. We then extracted the mean of the predicted HES5 levels, the 1146 
mean variance of expression, and the standard deviation of the predicted variance 1147 
for each relative change in repression threshold. In Supplementary Figure 11d we 1148 
plotted the mean predicted level of HES5 against the mean variance obtained in this 1149 
way, and we used the standard deviation at each relative value of the repression 1150 
threshold as an estimate of the confidence interval of this prediction. As expected, 1151 
the mean and variance of HES5 expression are positively correlated. The parameter 1152 
variation of the repression threshold was conducted on 4901 posterior samples. 1153 
 1154 
 1155 
Data availability 1156 
The authors declare that all data supporting the findings of this study are available 1157 
within the article and its supplementary information files or from the corresponding 1158 
author upon reasonable request. 1159 
 1160 
Single-cell Venus::HES5, H2B::mCherry intensity and positional information from ex-1161 
vivo movies are available in the source data and on request from the corresponding 1162 
authors. Simulations, data and code to generate Figs 6 and Supplementary Fig 10 1163 
are available online under https://github.com/kursawe/hesdynamics The raw movie 1164 
files are available through figshare DOI 10.6084/m9.figshare.8005652 . 1165 
 1166 
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The source data underlying Figs 1-5,7-8 and Supplementary Figs 1-9,11-12 are 1167 
provided as a Source Data file. 1168 
Code availability 1169 
Data fitting for detections of oscillations has been implemented in Matlab R2015a 1170 
using the GPML toolbox (Rassmussen and Hannes 2010) and custom designed 1171 
routines available at http://gaussianprocess.org/gpml/code/matlab/doc/. Code for 1172 
stochastic model of transcriptional auto-repression and Bayesian inference are 1173 
available online under https://github.com/kursawe/hesdynamics. Matlab custom 1174 
designed routines for analysis of FCS available on request. 1175 
 1176 
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Figure Legends 1423 
Figure 1. A quantitative transverse map of HES5 expression in the spinal cord. 1424 
a) Transverse slice of live Venus::HES5+/+ knock-in mouse spinal cord E10.5 ex vivo. 1425 
Box identifies ventral domain, A-apical, B-basal. Scale bar 50μm. b) 1426 
Immunofluorescence of E10.5 Venus::HES5 transverse slice of spinal cord. SOX2 - 1427 
progenitors, NeuN - neurons and endogenous Venus::HES5 signal. Scale bar 30μm. 1428 
c) Average FCS autocorrelation curve. 315 cells in ex-vivo E10.5 Venus::HES5+/+ 1429 
spinal cord ventral region. Inset - example fluorescence count rate from single point 1430 
within a nucleus. d) Nuclear Venus::HES5 concentration in  E10.5 Venus::HES5+/+ 1431 
ventral domain. 315 cells, 4 experiments. Mean=140nM, SD=52nM. e) Transverse 1432 
slice of live Venus::HES5+/+ mouse spinal cord E10.5 ex vivo. Draq5 nuclear stain. 1433 
Scale bar 200μm. f) Regions of interest from nuclear segmentation of e) with 1434 
grayscale Venus::HES5 intensity. g) Nuclear Venus::HES5 intensity (a.u) in a single 1435 
live ex-vivo E10.5 Venus::HES5+/+ transverse slice (e). n=586 cells. Mean=61a.u 1436 
SD=39a.u h) Nuclear Venus::HES5 concentration in E10.5 Venus::HES5+/+ embryos 1437 
across entire spinal cord. n=442 cells, 4 experiments. Mean=148nM, SD=58nM. i) 1438 
Quantile-quantile plot of nuclear Venus::HES5 concentration (h) vs nuclear 1439 
Venus::HES5 intensity (g)  for E10.5 homozygous embryos. Red line - linear fit over 1440 
middle 90% range. j) Quantitative map of nuclear Venus::HES5 concentration in 1441 
whole live E10.5 spinal cord. Colour bar shows Venus::HES5 concentration by 1442 
scaling intensity values according to linear fit of Q-Q plot in i). Scale bar 50μm. k) 1443 
Nuclear Venus::HES5 concentration by distance from ventricle in region 1 (upper box 1444 
in j) and region 2 (lower box in j)  l) Concentration difference between a cell and its 1445 
nearest neighbours for cells less than or greater than 50μm (region 1) from the 1446 
ventricle (n=154, n=73 cells respectively. p=0.0007 (***) in Mann-Whitney test), or 1447 
30μm (region 2) from the ventricle (n=91, n=135 cells respectively. p<0.0001 (***) in 1448 
Mann-Whitney test). m) Coefficient of variation in Venus::HES5 intensity between 1449 
cells less than or greater than 50μm from the ventricle in ventral domain in E10.5 1450 
Venus::HES5 embryos. (n=4 embryos, at least 24 cells per embryo, 2 experiments, 1451 
p=0.04 (*) in paired t-test.). Error bars – SD. Source data are provided in a Source 1452 
Data file. 1453 
 1454 
Figure 2. Clustering indicates distinct Venus::HES5 expression dynamics. 1455 
a) Schematic of snapshot Venus::HES5 intensity variability and b-d)possible non-1456 
mutually exclusive causes. b) Stable sub-populations of cells have different 1457 
expression levels. c) single state of cell can traverse all intensity levels d) cells 1458 
undergo one-way transition from high to low levels of expression. e) Schematic of 1459 
experimental approach to image Venus::HES5 expression dynamics from a single 1460 
endogenous locus. f) Snapshot of ex-vivo live E10.5 Venus::HES5 Sox1Cre:ERT2 1461 
Rosa26RH2B::mCherry spinal cord slice culture. Scale bar 40μm. g) Example single 1462 
cell traces of normalised Venus::HES5 protein expression in ex-vivo live E10.5 1463 
heterozygous Venus::HES5 spinal cord slice cultures. Individual H2B::mCherry+ cells 1464 
were tracked over time in slice cultures. Single cell Venus::HES5 intensity values 1465 
were normalised to the tissue mean intensity over time. h) Representative 1466 
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dendrogram from hierarchical clustering of standardised single cell Venus::HES5 1467 
protein dynamics in E10.5 heterozygous Venus::HES5 spinal cord slice culture in 1 1468 
experiment. Columns show standardised individual cell Venus::HES5 expression 1469 
dynamics in a heatmap aligned to start at t=0, the start of tracking. Rows represent 1470 
time points after start of individual cell tracking. 54 cells tracked for 12-hour time 1471 
window with 15-minute frame intervals. i) Mean Venus::HES5 expression dynamics 1472 
for cells in each cluster in a representative experiment corresponding to dendrogram 1473 
in e). (Cluster 1 - 11 cells, cluster 2 - 11 cells, cluster 3 - 21 cells, cluster 4 - 11 cells).  1474 
j) Example single cell traces for each cluster of normalised Venus::HES5 expression 1475 
in ex-vivo live E10.5 spinal cord slice cultures. k) Left - coefficient of variation (C.O.V) 1476 
of single-cell Venus::HES5 expression over time within 4, 8, 12,14 and 17.25 hour 1477 
windows. Cluster 1 – black, cluster 2 – sky blue, cluster 3- green, cluster 4 – pink. 1478 
181 cells, 3 experiments clustered separately, single points show C.O.V from a 1479 
single-cell timeseries. Right - C.O.V in Venus::HES5 protein levels between cells 1480 
measured at a single time point. 5 ex-vivo E10.5 Venus::HES5 slices in 2 1481 
experiments, single points show COV between cells in a single slice. Source data are 1482 
provided in a Source Data file. 1483 
 1484 
Figure 3. Single cell Venus::HES5 dynamics correlate with cell state. 1485 
a) Example single cell tracks for each cluster from 1 representative experiment. ‘*’ 1486 
denotes cell division. Dorso-ventral axis in μm from floorplate. b) Single cell tracks 1487 
(n=54) over 12-hours in a single E10.5 spinal cord slice movie. Black dotted line - 1488 
ventricle. Grey - ventricular zone and green - mantle zone measured by Sox2/NeuN 1489 
immunostaining of 2 ex-vivo slices. c) Average distance of single cell from ventricle 1490 
over 12-hour track. Cells from 3 experiments clustered separately. Kruskall-Wallis 1491 
with Dunn’s multiple comparisons test indicated cluster 1 vs 3 adjusted p-value = 1492 
0.0014 (**) d) Percentage of any cells found in 25μm windows from ventricle in each 1493 
cluster. 2-way ANOVA with Tukey multiple comparison test shows no difference 1494 
between clusters <50μm from ventricle. 76-100μm from ventricle cluster 3 vs 1 1495 
p<0.0001, 3 vs 2 p=0.0009, 3 vs 4 p=0.014. e) Displacement of cells in each cluster. 1496 
Dot - average start position, arrow - average finish position. f) Total distance travelled 1497 
of single cells. Line is mean with SD. Kruskal-Wallis test with Dunn’s multiple 1498 
comparison test shows cluster 1 vs 3 adjusted p=0.003 (**), cluster 3 vs 4 adjusted 1499 
p=0.0017 (**). g) Percentage of cells per cluster undergoing 0 or 1 divisions in 12 1500 
hours. Chi-squared test of frequency data p=0.0002. 181 cells, 3 experiments 1501 
clustered separately. Cluster 1 - black (n=27 cells), cluster 2 - sky blue (n=33 cells), 1502 
cluster 3 - green (n=67 cells), cluster 4 - pink (n=54 cells). Error bars – SD. Source 1503 
data are provided in a Source Data file. 1504 
 1505 
 1506 
Figure 4. Notch inhibition enriches for cluster 4-type Venus::HES5 dynamics 1507 
a) Relative Venus::HES5 intensity of E10.5 ex-vivo slices cultured in control DMSO 1508 
(black) or 2μM DBZ (pink). Error bars - SD (3 experiments). Endpoint intensity - 1509 
 40
Mann Whitney two-tailed test p=0.0095 (**). b) β-III tubulin (early neuronal marker) 1510 
staining of DMSO or 2μM DBZ treated E10.5 ex-vivo slices. fp – floorplate. Scale bar 1511 
70μm. c) Displacement of single cells away from ventricle in apico-basal axis in 1512 
control DMSO or 2μM DBZ treated E10.5 slices. Bold line - average, dashed line - 1513 
SD from 3 experiments. Two-tailed t-test p<0.0001 (****). d) Hierarchical clustering of 1514 
standardized single-cell Venus::HES5 expression in DMSO and 2μM DBZ treated 1515 
E10.5 ex-vivo slices. Columns show standardised individual cell Venus::HES5 1516 
expression dynamics in a heatmap. Rows represent time points after start of 1517 
individual cell tracking. Cells tracked for 12-hour time window with 15-minute frame 1518 
intervals. 295 cells, 3 experiments clustered together. Cluster labels defined using 1519 
clustering of DMSO alone. Pink – DMSO cells, green - DBZ cells. e) Percentage of 1520 
cells in each cluster in DMSO and 2μM DBZ treated E10.5 ex-vivo slices. Frequency 1521 
data subject to Chi-squared test showed p<0.0001 (****). DMSO n=100 cells, 2μM 1522 
DBZ n=195 cells, 3 experiments. Source data are provided in a Source Data file. 1523 
 1524 
Figure 5. Differentiating cells are oscillatory and progenitors are noisy  1525 
Example single-cell traces of Venus::HES5 expression subject to oscillatory test. a) 1526 
Raw single-cell Venus::HES5 intensity timeseries with overlaid long-term trend in 1527 
bold. b) Detrended single-cell Venus::HES5 intensity timeseries with overlaid OUOsc 1528 
oscillatory model in bold. c) Single-cell periods of Venus::HES5 protein dynamics 1529 
from oscillatory cells. Mean=3.3hours, SD=1.4hours. n=72 cells, 3 experiments. d) 1530 
Percentage of single cells classified as having oscillatory Venus::HES5 protein 1531 
expression in cluster 1+2 vs cluster 3+4. n = 3 experiments, p-value = 0.04 (*) in 1532 
Wilcoxon paired test, two-tailed. Single-cell raw Venus intensity was detrended and 1533 
subject to oscillatory test (see methods). e) Noise in single cell Venus::HES5 1534 
expression dynamics per cluster as measured by the squared standard deviation of 1535 
de-trended Venus::HES5 signal over time. Lines show mean, error bars - SD. 1536 
Kruskal-Wallis with Dunn’s multiple comparison test shows cluster 1 vs 3 adjusted 1537 
p=0.04 (*). 181 cells, 3 experiments clustered separately. Cluster 1 - black (n=27 1538 
cells), cluster 2 - sky blue (n=33 cells), cluster 3 - green (n=67 cells), cluster 4 - pink 1539 
(n=54 cells). f) Likelihood of a cell having oscillatory Venus::HES5 expression 1540 
indicated by LLR score plotted by average distance of the cell away from the 1541 
ventricle over 12-hour track. Bars show mean and error bars show SEM. Kruskal-1542 
Wallis with Dunn’s multiple comparison test shows 0-25μm vs 50+μm adjusted 1543 
p=0.03 (*). g) Noise in single cell Venus::HES5 expression dynamics plotted by 1544 
average distance of the cell away from the ventricle over 12-hour track. Bars show 1545 
mean and error bars show SEM. Kruskal-Wallis with Dunn’s multiple comparison test 1546 
shows 0-25μm vs 26-50 adjusted p= 0.0007 (***) and 0-25μm vs 50+μm adjusted 1547 
p=<0.0001 (****).  h) Example single-cell timeseries of relative Venus::HES5 protein 1548 
expression in ex-vivo live E10.5 Venus::HES5 spinal cord slice cultures showing 1549 
noisy to oscillatory transition in Venus::HES5 dynamics. Source data are provided in 1550 
a Source Data file. 1551 
 1552 
Figure 6. Hes5 network is poised at aperiodic to oscillatory transition point 1553 
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a) Schematic of stochastic model for genetic autorepression of HES5. b) Bayesian 1554 
posterior model predictions of HES5 periods. Periods are extracted from simulated 1555 
data of 12h duration using Hilbert transforms. Black line indicates mean of 1556 
experimentally measured periods. Mean=4.47 hours, SD=2.51 hours, n=4901 1557 
samples. c) Distribution of model predicted relative standard deviations (standard 1558 
deviation/mean) of HES5 expression over time. Mean =0.078, SD=0.023, n=4901 1559 
samples. The distribution approaches zero around 0.15, the experimentally 1560 
determined maximum value of standard deviation of Venus::HES5 over time (de-1561 
trended data) in proliferating progenitors in clusters 1 and 2 (Supplementary 1562 
Fig.10b). d-f) Ten example traces generated using the model are shown at three 1563 
different parameter points . The power spectrum does not have a dominant non-zero 1564 
peak in d) whereas the power spectra in e) and f) do have a dominant non-zero peak 1565 
with decreasing width from e) to f) showing increasing coherence. Parameter values 1566 
are (d) αm=0.64min-1, αp=17.32min-1, P0=88,288.6, τ=34min, n=5.59 (e) αm=39.93min-1567 
1, αp=21.56 min-1, P0=24,201.01, τ=33min, n=4.78 (f) αm=44.9min-1, αp=3.13min-1, 1568 
P0=35,080.2, τ=40min, n=5.62. The half-lives of the protein and mRNA are set to 90 1569 
and 30 minutes, respectively. g) Response curves in coherence when changing the 1570 
protein degradation rate (n=4901 samples). The black line is located at the 1571 
degradation rate corresponding to a 90 minutes HES5 protein half-life. h-i) Heatmaps 1572 
showing expected coherence for the stochastic model (h) and the deterministic 1573 
model (i) of HES5 expression as protein and mRNA degradation rates are changed. 1574 
The blue dots mark experimentally measured values for the protein and mRNA 1575 
degradation rates, corresponding to a 90 and 30 minute half-life, respectively. 1576 
Experimentally measured degradation rates are located on the slope of increasing 1577 
coherence values in the stochastic model, and in a region of no expected oscillations 1578 
in the deterministic model. j) Likelihood of inducing oscillations with less than 5hr 1579 
period from aperiodic fluctuations when changing individual parameters by 50% 1580 
(n=48503 samples). 1581 
 1582 
 1583 
Figure 7.HES5 oscillations on a downward trend increase fold-changes 1584 
a) Maximum peak-to-trough fold-change in single cell Venus::HES5 expression per 1585 
cluster. Kruskal-Wallis with Dunn’s multiple comparison test shows cluster 1 vs 3 1586 
adjusted p=0.0008 (***), cluster 1 vs 4 adjusted p<0.0001 (****). 181 cells, 3 1587 
experiments clustered separately. Cluster 1 (n=27 cells), cluster 2 (n=33 cells), 1588 
cluster 3 (n=67 cells), cluster 4 (n=54 cells). Peak:Trough fold change is calculated 1589 
from normalised Venus::HES5 expression including trend. Examples of single-cell 1590 
Venus::HES5 timeseries in cluster 3 with b) oscillatory and c) non-oscillatory 1591 
expression. Bold lines indicate model fit over normalized Venus::HES5 intensity. Plus 1592 
sign indicates peak and circle indicates trough in intensity values, fold-changes 1593 
between peak-trough are indicated at relevant peak. d) Mean peak-to-trough fold-1594 
change in oscillatory (n= 52 cells, 3 experiments) or non-oscillatory (n = 69, 3 1595 
experiments) single-cell Venus::HES5 expression in differentiating cells in cluster 3 1596 
and 4. p=0.027 (*) in Mann-Whitney test after 2 outliers removed. e) Example single-1597 
cell timeseries of mean normalized Venus::HES5 expression (red) from cluster 3 1598 
showing amplitude death (amplitude indicated by dashed line). f) Instantaneous 1599 
amplitudes from Hilbert transformation of de-trended single cell Venus::HES5 1600 
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expression observed over time. 121 cells from cluster 3 and 4 in 3 experiments 1601 
clustered separately. Student’s t-test were used to compare maximum amplitude 1602 
data in: cluster 3 against subsequent timepoints showing significant decay after 10h 1603 
p= 0.0470 (*), 12h -16h p<0.0001; cluster 4 showing significant decay after 14h p= 1604 
0.0153 (*) and p=0.0195 for 16h. Error bars – SD. Source data are provided in a 1605 
Source Data file. 1606 
 1607 
 1608 
Figure 8. HES5 oscillations during differentiation correlate with cell fate. 1609 
a) Immunofluorescence of E10.5 Venus::HES5 transverse slice of spinal cord ex-1610 
vivo. Endogenous Venus::HES5 signal, OLIG2 – motor neuron progenitors, Isl1/2 - 1611 
mature motor neurons. Measurement bar from floorplate to dorsal edge of OLIG2 1612 
domain 90μm. b) Distance of ventral and dorsal edge of the motor neuron domain 1613 
measured from the floorplate in ex-vivo spinal cord slice cultures. Bars indicate mean 1614 
and error bars indicate SD n=6 slices. c) Percentage of single cells in cluster 3&4 1615 
classified as having oscillatory Venus::HES5 protein expression <100μm and >100 1616 
μm from floorplate. All cells (n=121) and experiments (n=3) combined. Fisher’s exact 1617 
test performed on cell numbers in each category, p=0.004. d) Model of Venus::HES5 1618 
expression dynamics through cell-state transition from neural progenitor cell to 1619 
neuron. Neural progenitors have dynamic, noisy and aperiodic fluctuations in 1620 
Venus::HES5 protein expression. As cells transition towards neurons they have a 1621 
long-term decreasing trend in Venus::HES5 and are more likely to show short-term 1622 
oscillatory dynamics. Cells declining with oscillatory Venus::HES5 correlate with 1623 
interneuron fate, whereas declining non-oscillatory cells correlate with motor neuron 1624 
fate. Source data are provided in a Source Data file. 1625 
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Figure 3. Single-cell Venus::HES5 dynamics correlate with cell state 
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Figure 6. Hes5 network is poised at aperiodic to oscillatory transition point. 
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Figure 7. HES5 oscillations on a downward trend increase fold-changes 
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